data_2mo1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mo1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.879 0.371 . . . . 74.44 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.45 110.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.13 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.43 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.24 111.113 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.02 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 65.13 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.35 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 63.01 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 54.2 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.43 110.91 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.12 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 71.22 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.12 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.13 110.913 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 70.52 111.103 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.31 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.11 111.135 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.874 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.31 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.11 111.071 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.31 111.112 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.909 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.804 0.335 . . . . 73.02 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 70.31 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.44 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.14 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.22 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.823 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.52 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.23 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.5 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.891 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.914 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.11 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.41 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 64.33 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.21 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.2 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.13 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.44 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.13 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.14 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.914 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.34 111.048 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.22 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.53 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.43 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 71.13 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 73.23 110.914 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.43 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.41 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.51 111.159 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.92 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.2 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.45 110.888 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.04 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 70.51 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 72.13 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 74.13 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.03 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 72.51 112.489 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.42 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.33 111.151 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.917 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.913 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 70.11 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 74.24 111.147 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 64.24 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.13 111.074 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.42 111.128 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.1 110.899 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.837 0.351 . . . . 74.3 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.32 110.852 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.34 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.53 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 71.11 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 73.03 110.929 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 75.03 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.31 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 75.44 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.12 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.31 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 70.54 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.12 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.11 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.34 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.796 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.095 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 72.31 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 74.24 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.14 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 72.32 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.42 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.35 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 72.52 111.126 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.22 110.867 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.22 110.878 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.1 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.22 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 74.12 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 73.42 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.24 112.505 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.23 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 75.35 111.095 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.32 110.926 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.913 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 71.25 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.3 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.31 111.151 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.873 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.32 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.1 110.868 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.854 0.359 . . . . 74.14 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.11 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.919 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 62.14 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 61.21 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 72.33 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.22 110.848 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.915 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 75.03 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.02 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.32 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 64.21 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.11 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 74.31 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.35 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 72.22 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 72.1 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.1 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.915 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 72.44 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.04 111.063 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 74.45 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 70.33 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.825 0.345 . . . . 72.12 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.22 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.41 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.22 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.34 110.877 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.01 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.14 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.45 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.24 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.22 110.91 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 75.53 112.471 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 71.34 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.03 111.122 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.893 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.882 0.372 . . . . 70.4 111.118 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.101 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.21 110.853 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 75.32 110.908 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 72.21 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.21 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.42 111.138 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.01 110.864 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.828 0.346 . . . . 75.11 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.892 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.44 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 65.25 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.31 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.42 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.894 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 71.11 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 73.42 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.52 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.54 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.15 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 71.34 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.11 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 73.32 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.12 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.13 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.894 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 75.35 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.913 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.44 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.4 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 75.55 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 75.11 110.898 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 75.32 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 73.45 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.854 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.02 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.84 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 63.54 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 74.01 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 73.22 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.11 112.493 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 75.25 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.113 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.2 110.879 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.891 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 73.51 111.098 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 26' ' ' VAL . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.12 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.846 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.14 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.092 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.093 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.91 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.801 0.334 . . . . 74.33 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.868 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 54.14 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 74.34 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.44 110.861 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 71.1 111.152 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.873 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.53 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 74.22 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.34 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.4 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.53 110.879 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.01 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 62.35 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 74.42 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.32 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 75.4 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.865 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.43 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.43 111.106 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 55.11 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.123 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.859 0.362 . . . . 75.34 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.35 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.51 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.43 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.121 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.44 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.876 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.15 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.35 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 74.42 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 70.13 112.485 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 75.11 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.34 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.54 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.935 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 74.21 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.15 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.3 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.55 110.853 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 75.34 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 53.33 111.096 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.45 111.119 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.02 110.862 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.817 0.341 . . . . 75.13 110.917 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 75.32 110.898 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.33 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.42 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.5 111.12 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 71.43 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.55 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 60.14 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 75.24 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.03 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.52 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 74.34 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.43 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 73.4 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.11 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 74.34 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.31 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 71.25 111.114 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 73.1 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.15 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.11 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.01 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.884 0.373 . . . . 73.25 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.907 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.54 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 75.52 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.43 111.128 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.45 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.34 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 61.33 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 74.34 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.15 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.34 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.25 111.139 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.612 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.911 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.872 0.368 . . . . 74.13 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.54 111.141 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.893 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.3 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.33 111.144 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.31 111.08 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.2 110.88 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 74.53 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.41 110.848 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 74.33 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.2 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.32 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 64.15 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.12 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.883 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 64.42 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 75.24 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.12 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 72.32 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 73.12 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 73.34 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 74.11 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 74.4 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.4 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.883 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 75.43 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.34 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.848 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.875 0.369 . . . . 75.32 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.44 110.866 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 74.12 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.105 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.88 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.33 110.826 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 63.31 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 52.31 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.15 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 54.41 112.466 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.51 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.41 111.161 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 64.21 110.912 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.941 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.846 0.355 . . . . 73.35 111.103 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.52 111.111 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.44 110.873 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 72.43 111.161 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.06 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.51 111.121 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 73.54 110.929 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.805 0.336 . . . . 73.33 110.954 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.41 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.9 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 63.51 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.33 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.34 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 70.12 111.133 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.04 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 74.41 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 73.4 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 71.32 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 73.54 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 73.13 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 74.41 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 74.21 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 72.12 112.367 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 72.43 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.067 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 75.23 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.23 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.53 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.22 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 63.42 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.52 110.909 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 62.31 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.21 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.21 111.118 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.31 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.15 110.841 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.52 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.32 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 74.24 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 70.0 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.44 112.544 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.24 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.134 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.42 110.853 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.871 0.367 . . . . 74.14 111.177 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 70.54 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.53 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.887 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 74.3 111.116 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.869 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.811 0.338 . . . . 72.55 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.89 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 51.24 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.51 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.34 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.23 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.89 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.31 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.21 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.03 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 64.21 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.43 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 55.52 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.22 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 74.25 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.14 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.45 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 74.3 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.45 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 73.41 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 74.44 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 75.51 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.42 111.135 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.42 110.933 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 71.42 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.34 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.31 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.34 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.106 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.625 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.35 110.926 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.916 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.864 0.364 . . . . 74.32 111.152 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.52 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.24 111.158 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.81 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.42 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 74.4 111.118 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.35 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.904 179.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.879 0.371 . . . . 73.03 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.843 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.15 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.23 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.51 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.44 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.34 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.34 110.928 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 61.24 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.33 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.54 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.21 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 74.31 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 51.21 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.15 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.23 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.13 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.082 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.51 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.54 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 71.02 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.54 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.873 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 46' ' ' HIS . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.54 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.361 . . . . 72.0 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 74.04 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.05 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.03 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.3 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.32 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.41 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 73.45 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 64.51 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.42 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 74.13 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.22 111.12 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.13 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.32 110.867 -179.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 75.35 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 71.22 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.45 110.841 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.131 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.3 111.13 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.1 110.897 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.838 0.351 . . . . 74.33 110.949 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 74.02 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.21 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.4 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.41 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.183 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.84 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.23 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 72.25 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.11 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 70.11 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 54.43 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.05 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 51.02 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 71.41 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.103 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.54 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 65.4 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 71.01 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.893 0.378 . . . . 75.13 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.22 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 75.42 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.111 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.53 110.904 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.53 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 70.22 110.816 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.42 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.21 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 42.12 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 71.23 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.51 111.122 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.618 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.906 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.915 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 64.42 111.149 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.21 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.4 111.156 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.05 110.861 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.03 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.148 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 55.43 110.891 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.854 0.359 . . . . 75.22 110.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.44 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.21 110.882 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.44 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.54 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.41 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.2 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.853 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.892 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.24 110.866 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.31 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 73.32 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 75.11 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 70.21 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.14 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 74.41 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.33 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.892 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.15 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.34 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.406 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.406 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.23 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 73.44 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.03 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 74.32 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 63.43 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 75.15 110.907 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.52 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.885 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 63.32 111.099 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 62.02 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.11 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 75.34 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.11 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 41.31 112.482 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.51 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.14 111.135 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.885 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.944 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.893 0.377 . . . . 74.14 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.136 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.33 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.88 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.23 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.079 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.12 111.13 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 75.44 110.936 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.41 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.918 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.53 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 73.21 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.43 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.917 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.32 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 61.24 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 62.3 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 51.42 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.24 110.905 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.05 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.44 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 75.44 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.45 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.15 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.54 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 72.11 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.42 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.841 0.353 . . . . 72.41 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.12 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 74.34 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 71.53 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.32 111.138 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.33 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.878 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 73.11 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 75.14 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.43 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.33 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 63.11 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.33 112.516 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 71.31 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 75.24 111.098 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 74.21 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.89 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.868 0.366 . . . . 73.44 111.123 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.42 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 70.1 110.88 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.889 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 74.25 111.149 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.11 111.095 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.128 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.2 110.858 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.844 0.354 . . . . 74.2 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.23 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 61.15 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.34 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.33 111.13 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 54.44 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.44 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.13 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 73.1 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 74.54 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 54.5 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 74.31 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.23 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 74.13 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 65.23 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 65.22 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.905 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 72.12 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.14 111.079 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.45 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.1 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.866 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.4 111.124 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.877 0.37 . . . . 74.34 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.12 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.02 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.02 111.103 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.872 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.885 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.32 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.32 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.2 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.54 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 63.11 110.866 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.04 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.23 111.066 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.613 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 73.03 110.911 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.23 110.959 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 74.33 111.107 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.05 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.096 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.853 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.05 110.866 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 75.25 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.092 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.15 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.876 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.866 0.365 . . . . 74.02 110.938 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 62.45 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.912 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.41 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.34 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 71.55 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.34 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.33 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.894 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 75.21 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.15 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.3 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.35 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 71.12 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.03 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.53 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.35 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.41 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.894 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 73.32 111.075 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.51 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 74.3 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.14 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.383 . . . . 74.42 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.12 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.33 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 75.25 111.143 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.43 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.922 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.22 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.13 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.15 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.21 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.34 110.945 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.22 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.43 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.127 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.934 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.878 -179.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.845 0.355 . . . . 72.44 111.118 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.3 111.14 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.867 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.866 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.099 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.45 111.128 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.884 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.229 0.021 0 CA-C-O 120.845 0.355 . . . . 74.21 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.879 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 73.3 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.44 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.889 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.407 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.45 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.908 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.42 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 75.41 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 75.11 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.3 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 73.2 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.33 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.14 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.43 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 74.34 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.908 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 72.43 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.122 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.35 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.03 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.23 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.41 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.85 0.357 . . . . 74.21 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 70.1 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.1 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.24 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.43 111.136 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.34 110.844 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.31 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.42 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.32 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.14 112.463 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.35 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 74.24 111.162 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.92 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.8 0.333 . . . . 74.32 111.17 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.126 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 71.55 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.899 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 73.33 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.14 111.146 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 74.12 111.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.827 0.346 . . . . 74.33 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.863 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.45 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.53 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.22 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.53 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.45 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.863 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.35 110.908 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 73.35 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.12 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 72.44 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.53 112.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.52 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.35 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 75.43 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.863 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 73.05 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.095 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 74.41 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.51 110.811 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.165 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 64.45 110.866 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.22 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.33 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.87 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.33 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.854 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.11 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.12 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 74.43 112.473 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 72.44 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.42 111.138 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.905 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.899 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 63.12 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.133 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.42 110.879 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.891 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.52 111.158 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.094 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.13 111.057 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 71.21 110.909 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 65.53 110.936 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.859 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 64.43 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 63.51 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.35 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.1 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.35 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.33 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 64.24 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.51 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 64.42 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.51 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.21 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 73.22 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.919 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.13 111.108 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.53 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.13 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 64.21 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 73.01 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.11 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.12 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.45 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.44 111.127 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.03 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.881 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.4 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 63.52 111.13 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 71.33 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.51 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.03 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 74.41 110.923 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.368 . . . . 74.22 111.138 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 72.34 111.143 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 70.34 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 73.51 110.865 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.45 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.42 111.145 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.43 110.853 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.23 0.033 0 CA-C-O 120.826 0.346 . . . . 74.52 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 72.22 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 54.24 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.11 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.22 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.54 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.901 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.01 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.32 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.1 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 73.43 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 72.32 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 73.43 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.54 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.35 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.32 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.22 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.35 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.919 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 71.21 111.11 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.31 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 65.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.44 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.31 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.837 0.351 . . . . 74.54 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 74.22 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.23 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.13 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.091 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.22 110.911 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.15 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.135 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.14 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.51 112.452 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.31 110.84 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.01 111.105 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.478 ' NE2' ' HB2' ' A' ' 7' ' ' LYS . 1.3 mm-40 -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.888 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.41 110.929 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.822 0.344 . . . . 71.22 111.112 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 71.05 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.157 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.878 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.14 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 71.14 111.089 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.11 111.133 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.904 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 75.51 110.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 71.3 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.24 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.53 110.919 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 75.22 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.43 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.14 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.53 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 64.1 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 75.53 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 74.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.22 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.21 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.55 111.084 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.1 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.13 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 63.21 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -118.05 148.45 42.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.886 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.45 110.895 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.13 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.43 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.24 111.113 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.92 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.02 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 65.13 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.35 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 63.01 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 54.2 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.43 110.91 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.12 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 71.22 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.12 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 6.3 pt20 -100.23 -172.31 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.13 110.913 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -60.17 -24.99 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 65.32 110.838 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 96.1 mt-10 -50.89 -75.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 73.03 110.887 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.81 -66.39 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 73.13 112.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 167.14 25.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 64.05 112.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.46 -175.6 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 73.33 110.846 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.26 152.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 70.52 111.103 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.31 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.11 111.135 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.874 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.42 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.31 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.11 111.071 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.31 111.112 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.35 89.88 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.909 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.04 172.22 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 64.53 111.098 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.83 76.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.856 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.88 -118.54 3.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.76 -0.733 . . . . 74.35 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -65.54 112.29 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 71.45 110.885 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -99.96 49.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.05 110.858 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.8 m -118.47 135.21 54.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 71.05 111.122 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.09 179.07 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.911 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 70.31 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.44 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.14 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.22 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.823 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.52 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.23 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.5 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.891 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.914 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.11 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.41 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 64.33 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.21 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.2 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.13 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.44 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.13 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.14 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.914 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.34 111.048 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.22 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.53 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 71.43 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 71.13 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.89 0.376 . . . . 65.03 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -130.34 145.13 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.914 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.43 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.41 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.51 111.159 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.92 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.2 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.45 110.888 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 75.15 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.04 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 70.51 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 72.13 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 74.13 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.03 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 72.51 112.489 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.42 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.33 111.151 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.917 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -99.23 -174.43 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.45 -24.66 65.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 54.21 110.926 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.99 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.21 110.888 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 -68.46 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.745 . . . . 64.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 165.74 29.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 63.24 112.362 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -80.32 -175.3 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.849 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.4 151.31 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 70.11 111.188 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 74.24 111.147 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 64.24 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.13 111.074 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.42 111.128 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.24 86.43 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.1 110.899 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 174.75 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.133 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.64 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.857 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.52 -147.96 17.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 54.23 112.467 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.05 111.85 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 71.4 110.895 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -64.55 101.76 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.25 110.838 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -152.5 135.98 16.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 64.43 111.152 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -118.48 164.44 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.898 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.32 110.852 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.34 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.53 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 71.11 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 73.03 110.929 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 75.03 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.31 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 75.44 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.12 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.31 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 70.54 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.12 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.11 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.34 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.796 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.095 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 72.31 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 74.24 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 65.21 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.14 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 71.44 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -126.98 131.86 50.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.32 110.897 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.42 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.35 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 72.52 111.126 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.22 110.867 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.22 110.878 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.1 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.22 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 74.12 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 73.42 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.24 112.505 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.23 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 75.35 111.095 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 71.32 110.926 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -167.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.913 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.68 -27.15 68.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.872 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.87 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.463 . . . . 74.12 110.922 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.54 -66.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 74.24 112.504 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 165.81 29.66 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.639 2.226 . . . . 74.34 112.371 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.73 171.65 13.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 74.53 110.867 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.26 151.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.166 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.3 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.31 111.151 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.873 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.32 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -110.49 87.68 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.1 110.868 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.48 172.31 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.51 111.061 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.21 75.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.907 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.9 140.01 5.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.747 . . . . 64.05 112.478 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -54.03 110.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.54 110.908 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -152.67 179.3 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.877 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -132.48 -178.55 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.166 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.14 176.83 4.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.14 110.896 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.11 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.919 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 62.14 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 61.21 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 72.33 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.22 110.848 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.915 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 75.03 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.02 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.32 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 64.21 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.11 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 74.31 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.35 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 72.22 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 72.1 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.1 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.915 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 72.44 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.04 111.063 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 74.45 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 70.33 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 73.11 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -130.47 155.4 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 72.12 110.887 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.22 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.41 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.22 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.12 111.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.34 110.877 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.01 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.14 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.45 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.24 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.22 110.91 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 75.53 112.471 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 71.34 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.03 111.122 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 -166.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.893 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -69.12 -27.65 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 63.41 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.13 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.01 110.913 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -66.5 0.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.689 -0.767 . . . . 64.44 112.431 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 164.12 35.75 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.721 2.281 . . . . 64.51 112.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.94 -169.85 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.41 151.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 70.4 111.118 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.101 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.21 110.853 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 75.32 110.908 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 72.21 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.21 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.42 111.138 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.35 93.39 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.01 110.864 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.74 179.08 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 70.41 111.136 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.53 77.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.22 110.858 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.12 -117.82 3.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 72.42 112.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -70.99 110.04 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 74.15 110.885 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.78 58.11 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.895 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -121.45 138.5 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 74.4 111.171 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mt -109.26 169.56 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.941 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.892 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.44 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 65.25 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.31 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.42 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.894 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 71.11 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 73.42 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.52 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.54 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.15 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 71.34 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.11 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 73.32 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 73.12 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.13 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.894 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 75.35 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.22 110.913 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.44 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.4 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.867 0.365 . . . . 71.33 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -118.13 145.61 44.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.55 110.893 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 75.11 110.898 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 75.32 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 73.45 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.854 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.02 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.52 110.84 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 63.54 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 74.01 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 73.22 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.11 112.493 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 75.25 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.113 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.2 110.879 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.79 175.31 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.41 -23.21 14.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 72.12 110.905 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.55 -72.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.01 110.832 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.9 -69.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 61.22 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 166.12 28.75 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 72.24 112.329 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.42 -173.26 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.13 110.881 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -143.48 151.75 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.51 111.098 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 26' ' ' VAL . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.12 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.52 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.846 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.14 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.092 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.093 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.93 92.01 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.91 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.43 168.31 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 64.42 111.094 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.24 74.4 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.87 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.91 163.23 11.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 53.21 112.523 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -55.66 110.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 73.43 110.922 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -142.8 -173.79 3.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 74.01 110.898 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.5 t -162.96 174.62 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 73.22 111.165 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.6 mt -108.99 159.84 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 74.33 110.91 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.868 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 54.14 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 74.34 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.44 110.861 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 71.1 111.152 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.873 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.53 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 74.22 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.34 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.4 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.53 110.879 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.01 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 62.35 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 74.42 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.32 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 75.4 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.865 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.43 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.43 111.106 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 55.11 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.123 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.894 0.378 . . . . 73.54 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -111.75 129.45 56.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.35 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.51 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.43 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.121 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.44 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.876 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.15 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.35 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 74.42 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 70.13 112.485 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 75.11 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.34 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.54 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.84 -168.24 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.935 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.03 -29.14 70.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 61.33 110.889 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -46.86 -72.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.899 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.48 -66.7 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.493 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 164.54 34.16 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 75.32 112.304 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -178.87 6.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.57 151.12 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.151 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.15 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.3 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.55 110.853 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 75.34 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 53.33 111.096 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.45 111.119 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -105.51 90.76 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.02 110.862 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.44 170.38 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 75.44 111.109 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 78.24 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.43 110.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.76 -117.58 3.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 71.34 112.489 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -82.26 110.87 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 72.1 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 122.98 46.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.41 110.919 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -160.0 134.9 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.11 111.134 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.14 158.26 17.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.13 110.917 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 75.32 110.898 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.33 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 65.42 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.5 111.12 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 71.43 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.55 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 60.14 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 75.24 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.03 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.52 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 74.34 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.43 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 73.4 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.11 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 74.34 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.31 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 71.25 111.114 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 73.1 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.15 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.11 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.01 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.855 0.36 . . . . 73.43 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -118.76 149.7 41.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.882 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.907 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.54 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 75.52 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.43 111.128 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.45 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.34 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 61.33 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 74.34 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.15 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.34 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.25 111.139 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.612 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.911 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.48 -179.12 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.926 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -21.52 23.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 71.42 110.858 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.16 -73.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.843 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.71 -68.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 63.11 112.52 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 168.14 22.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 63.02 112.369 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.0 172.88 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.41 110.898 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.83 150.75 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.157 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.54 111.141 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.893 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.3 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.33 111.144 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 74.31 111.08 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -112.84 85.8 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.2 110.88 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.47 177.72 4.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.092 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.4 74.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.832 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.65 -117.59 3.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 75.01 112.484 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -87.81 110.07 20.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 74.24 110.873 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -77.03 125.82 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.839 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -166.28 122.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.172 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt -108.87 -178.03 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.93 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.13 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.41 110.848 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 74.33 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.2 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.32 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 64.15 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.12 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.883 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 64.42 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 75.24 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.12 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 72.32 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 73.12 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 73.34 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 74.11 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 74.4 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.4 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.883 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 75.43 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.34 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.848 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 71.41 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -110.99 128.89 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 75.32 110.872 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.44 110.866 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 74.12 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.105 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.88 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.33 110.826 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 63.31 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.41 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 52.31 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.15 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 54.41 112.466 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.51 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.41 111.161 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 64.21 110.912 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 12.1 pt20 -106.25 -169.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.941 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.06 -26.11 66.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.842 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 13.6 mm-40 -49.77 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 71.44 110.898 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.64 -66.48 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 65.14 112.498 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 165.64 30.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.652 2.235 . . . . 64.34 112.336 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.77 178.0 8.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.53 110.891 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.83 151.07 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 73.35 111.103 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.52 111.111 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.44 110.873 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 72.43 111.161 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.06 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.51 111.121 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -105.79 92.09 4.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 73.54 110.929 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.3 171.94 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 64.15 111.125 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.03 74.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.2 110.867 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.87 138.05 5.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 72.53 112.468 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -52.54 124.83 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 74.24 110.899 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.34 129.19 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 75.12 110.86 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.5 t -81.01 174.65 11.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 73.13 111.13 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -109.61 168.18 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 73.33 110.954 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.41 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.9 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 63.51 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.33 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.34 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 70.12 111.133 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.04 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 74.41 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 73.4 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 71.32 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 73.54 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 73.13 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 74.41 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 74.21 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 72.12 112.367 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 72.43 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.41 111.067 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 75.23 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 75.23 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.53 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.22 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 75.22 110.891 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -121.66 149.85 42.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 63.42 110.892 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.52 110.909 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 62.31 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.21 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.21 111.118 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.31 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.15 110.841 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.52 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.32 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 74.24 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 70.0 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.44 112.544 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.24 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.134 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -105.17 -172.0 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.42 110.853 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -22.29 61.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.53 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -54.61 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 72.02 110.892 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.24 -67.94 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 70.43 112.517 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.3 35.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.218 . . . . 53.34 112.354 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -82.29 -173.71 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.8 151.55 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.177 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 70.54 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.53 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.887 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 74.3 111.116 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -108.76 91.63 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.53 -179.58 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.41 111.064 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.48 74.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 73.02 110.843 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 139.83 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 64.0 112.49 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -53.31 110.31 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 75.52 110.868 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -159.82 166.81 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 75.11 110.825 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.3 p -115.79 -173.88 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 73.02 111.147 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 165.6 11.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 72.55 110.966 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.89 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 51.24 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.51 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.34 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.23 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.89 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.31 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.21 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.03 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 64.21 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.43 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 55.52 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.22 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 74.25 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.14 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.45 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.2 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 74.3 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.45 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.848 0.356 . . . . 74.12 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -122.88 152.54 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.897 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 74.44 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 75.51 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.42 111.135 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.42 110.933 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 71.42 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.34 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.31 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.34 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.106 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.625 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.35 110.926 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.37 -169.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.916 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -84.04 -20.59 32.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.44 110.859 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -132.65 77.39 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.33 110.871 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 74.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 74.42 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 164.41 34.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 74.21 112.346 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.3 91.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 73.14 110.849 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -116.05 147.29 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.32 111.152 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.52 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.24 111.158 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.81 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.42 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 74.4 111.118 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.35 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.83 86.23 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.12 174.88 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 53.31 111.129 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.76 76.66 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.879 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.87 -117.93 3.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 72.25 112.503 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -67.92 110.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 75.4 110.907 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -85.82 89.83 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.01 110.883 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -158.07 145.88 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 63.13 111.122 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.72 166.19 12.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 73.03 110.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.13 110.843 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.15 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.23 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.51 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.44 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.34 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.34 110.928 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 61.24 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.33 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.54 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.21 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 74.31 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 51.21 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.15 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.23 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.13 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 72.12 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.082 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.51 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.54 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 71.02 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.54 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.873 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 46' ' ' HIS . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.54 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.815 0.34 . . . . 74.35 110.903 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -118.16 152.93 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 72.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.54 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 74.04 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.05 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.03 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.3 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.32 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.41 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 73.45 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 64.51 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.42 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 74.13 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.22 111.12 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.13 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -115.2 -168.16 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.32 110.867 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.62 -23.17 29.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 64.55 110.869 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -138.66 79.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 63.33 110.837 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 68.29 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 64.34 112.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 175.39 8.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 75.33 112.354 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.16 73.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 61.44 110.87 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.44 146.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 75.35 111.1 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 71.22 111.121 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.45 110.841 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.131 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.3 111.13 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -112.04 94.14 4.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.1 110.897 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.07 179.28 6.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.073 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -99.68 74.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.884 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.68 127.97 3.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 61.32 112.489 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -52.6 111.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 74.13 110.917 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.61 -169.45 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.927 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -128.26 179.04 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.111 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.69 163.76 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.949 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 74.02 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.21 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.4 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.41 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.183 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.84 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.23 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 72.25 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 71.32 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.11 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 70.11 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 54.43 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.05 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 51.02 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 71.41 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.103 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.54 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 65.4 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 71.01 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.834 0.349 . . . . 75.41 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -108.63 172.15 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.881 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 75.04 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.22 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 75.42 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.111 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.53 110.904 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.53 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 70.22 110.816 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 75.21 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.42 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.21 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 42.12 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 71.23 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.51 111.122 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.618 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.906 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.57 173.99 10.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.915 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -70.37 -16.11 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.22 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -137.6 76.79 1.6 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 73.13 110.896 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.66 72.21 0.51 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.762 . . . . 24.32 112.503 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 166.22 28.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 74.11 112.36 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.35 81.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 64.13 110.879 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.06 151.15 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.42 111.149 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.21 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.4 111.156 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.05 110.861 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.03 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.148 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -99.95 87.86 3.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 55.43 110.891 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.37 166.38 23.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 64.22 111.102 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.65 74.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.44 110.888 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.78 -159.34 17.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 63.44 112.514 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -96.67 111.06 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 73.33 110.85 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.45 110.36 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.24 110.85 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.2 p -79.73 -175.7 5.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 64.14 111.16 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.0 169.3 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.859 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.44 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.21 110.882 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.44 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.54 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.41 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.2 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.853 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.892 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.24 110.866 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.31 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 73.32 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 75.11 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 70.21 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.14 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 74.41 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.33 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.892 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 73.15 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.34 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.406 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.406 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 75.23 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.788 0.328 . . . . 74.5 110.886 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -101.47 170.96 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 73.44 110.874 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.1 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.03 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 74.32 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 63.43 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 75.15 110.907 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.52 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.885 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 63.32 111.099 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 62.02 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.11 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 75.34 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.11 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 41.31 112.482 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.51 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.14 111.135 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.885 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.62 -175.61 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.944 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.49 -21.35 62.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 62.3 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -52.74 -72.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.11 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.23 -68.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.742 . . . . 71.42 112.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 168.78 20.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 65.11 112.397 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -89.2 177.43 6.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.22 110.862 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.89 151.53 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.115 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 73.32 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.136 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.33 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.88 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.23 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.079 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.12 111.13 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -112.1 86.56 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.72 -179.94 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 70.31 111.061 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.2 74.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 73.52 110.828 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.69 139.38 5.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 72.35 112.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -52.57 110.09 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 74.34 110.859 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -169.88 165.83 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 72.44 110.866 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 p -115.85 -175.28 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.34 111.191 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.95 179.25 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.428 . . . . 75.44 110.936 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.41 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.918 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.53 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 73.21 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.43 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.917 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.32 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 61.24 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 62.3 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 51.42 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.24 110.905 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.05 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.44 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 75.44 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.45 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.15 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.54 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.33 111.122 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 72.11 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.42 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 72.43 110.881 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.1 145.97 48.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.878 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.12 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 74.34 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 71.53 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.32 111.138 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.33 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.878 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 73.11 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 75.14 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.43 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.33 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 63.11 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.33 112.516 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 71.31 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 75.24 111.098 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 74.21 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -105.42 -168.69 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.54 110.89 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.51 -26.97 62.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.42 110.874 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.55 -74.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 73.02 110.943 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.81 -65.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 64.41 112.447 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.691 2.261 . . . . 72.53 112.37 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 169.66 17.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.876 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -128.19 151.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.44 111.123 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.42 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 70.1 110.88 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.889 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 74.25 111.149 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.11 111.095 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.22 111.128 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.23 86.78 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.2 110.858 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.91 163.79 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 72.23 111.088 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.08 74.37 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 73.51 110.835 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.86 -162.35 15.65 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.801 -0.714 . . . . 74.34 112.489 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -96.53 130.58 43.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 74.3 110.847 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.95 -178.78 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.1 110.878 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.5 p -139.37 -174.61 3.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.117 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.18 164.88 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.23 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 61.15 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.34 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.33 111.13 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 54.44 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.44 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.905 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.13 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 73.1 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 74.54 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 54.5 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 74.31 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.23 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 74.13 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 65.23 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 65.22 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.905 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 72.12 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.14 111.079 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.45 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.1 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.866 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.4 111.124 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 63.42 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -108.79 163.4 13.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.34 110.856 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.12 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.02 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.02 111.103 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.872 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.885 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.44 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.32 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.32 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.2 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.54 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 63.11 110.866 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.04 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.23 111.066 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.613 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 73.03 110.911 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -101.25 -174.47 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 63.23 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.65 -23.44 66.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 75.12 110.851 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.91 -69.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.874 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.7 -68.1 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 61.34 112.493 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.42 21.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 73.11 112.324 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -88.27 -176.48 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 61.55 110.902 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.63 151.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.107 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.05 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.096 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.853 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.05 110.866 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 75.25 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.092 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.15 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.14 89.23 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.876 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.2 174.52 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 71.55 111.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.29 76.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.848 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.02 -154.69 16.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 64.41 112.5 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.62 116.03 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 74.22 110.91 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -154.8 169.21 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.881 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.4 p -149.39 175.22 11.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.23 111.144 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.05 169.05 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 74.02 110.938 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 62.45 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.912 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.41 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.34 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 71.55 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.34 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.33 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.894 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 75.21 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.15 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.3 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.35 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 71.12 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.03 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.53 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.35 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.41 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.894 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 73.32 111.075 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.51 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.53 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 74.3 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.14 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 74.24 110.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -114.96 141.55 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 74.42 110.866 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.12 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.33 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 75.25 111.143 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.43 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.922 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.22 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.13 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.15 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.21 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.34 110.945 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.22 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.43 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.127 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.934 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -112.66 -171.39 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.878 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -84.23 -18.68 35.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 65.11 110.899 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.36 78.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 65.41 110.871 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 73.69 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 75.14 112.457 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 163.2 39.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 72.32 112.371 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.24 88.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 65.41 110.891 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.29 149.46 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 72.44 111.118 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.3 111.14 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.867 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.866 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 75.4 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.099 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.45 111.128 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.37 86.78 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.884 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.85 169.3 16.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 75.1 111.097 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.43 74.48 3.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 75.53 110.852 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.6 139.42 5.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 60.44 112.49 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -52.59 110.32 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 62.1 110.89 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -138.29 -170.14 2.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 75.53 110.838 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -143.26 174.47 10.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 74.41 111.166 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.01 163.4 13.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.924 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 75.44 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.879 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 73.3 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.44 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.889 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.407 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.32 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.45 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.908 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.42 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 75.41 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 75.11 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.3 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 73.2 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.33 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.14 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.43 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 72.43 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 74.34 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.908 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 72.43 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.122 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.35 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.03 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.23 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.41 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.852 0.358 . . . . 70.45 110.901 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -146.83 159.34 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 74.21 110.896 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 70.1 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.1 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 73.24 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.43 111.136 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.34 110.844 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.31 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.42 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.32 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.14 112.463 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.35 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 74.24 111.162 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -95.05 -169.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.92 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.01 -18.56 47.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 64.33 110.932 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -55.73 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 74.21 110.885 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.44 -65.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 75.22 112.494 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.39 27.8 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 74.52 112.357 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 -173.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.9 152.26 22.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.17 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.34 111.126 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 71.55 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.899 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 73.33 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.14 111.146 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 74.12 111.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -112.02 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.26 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.33 111.072 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.66 76.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 73.34 110.834 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.67 -121.1 4.24 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.756 -0.735 . . . . 74.55 112.498 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -55.14 110.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 75.42 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.75 45.72 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 73.41 110.869 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -121.21 142.56 49.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 75.42 111.123 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.96 175.88 5.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.943 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.863 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.45 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.53 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.22 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.53 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.45 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.863 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.35 110.908 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 73.35 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.12 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 72.44 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.53 112.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.23 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.52 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.35 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 75.43 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.863 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 73.05 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.095 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.33 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 74.41 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.51 110.811 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.165 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 74.21 110.869 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.9 150.34 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.45 110.866 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.22 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.33 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.87 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.33 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.02 110.854 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.11 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.12 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 74.43 112.473 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 72.44 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.42 111.138 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.905 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -107.13 -171.81 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.899 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.45 -23.81 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -52.67 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.11 110.868 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.23 -66.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 74.53 112.458 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 164.71 33.46 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.21 112.384 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.44 -174.09 4.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.22 110.874 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.83 151.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 63.12 111.14 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.133 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.42 110.879 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.891 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.52 111.158 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.094 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.13 111.057 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.99 89.53 3.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 71.21 110.909 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.5 176.89 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 72.54 111.066 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.17 76.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 75.44 110.878 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.56 -137.2 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 75.53 112.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.98 110.11 6.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 74.32 110.88 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.4 mtm-85 -75.27 127.03 32.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.912 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -166.46 131.19 2.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.2 111.141 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp -114.32 164.05 14.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 65.53 110.936 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.859 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 64.43 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 63.51 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.22 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.02 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.35 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.1 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.35 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.33 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 64.24 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.51 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 64.42 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.51 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.21 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 73.22 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.919 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.13 111.108 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.53 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.13 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.3 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 64.21 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 65.23 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -141.65 138.35 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 73.01 110.894 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.11 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.12 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.45 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.44 111.127 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.03 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.881 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.4 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 63.52 111.13 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 71.33 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.51 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.03 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -96.53 -169.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 74.41 110.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.56 -23.7 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.888 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.2 mm-40 -51.3 -70.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 72.21 110.887 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.55 -66.9 0.24 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 73.13 112.527 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 165.9 29.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.248 . . . . 73.23 112.325 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.66 -174.87 5.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 75.43 110.845 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.47 151.59 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.138 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 72.34 111.143 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 70.34 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 73.51 110.865 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.45 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.42 111.145 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.35 89.32 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.43 110.853 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.7 175.74 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 65.22 111.116 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -102.0 74.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.913 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.66 132.84 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 63.41 112.476 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -52.69 110.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 74.44 110.851 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -146.87 -169.7 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.891 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -134.71 177.02 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 71.33 111.126 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt -108.85 163.55 13.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 72.22 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.32 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 54.24 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.11 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.22 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.54 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.901 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.01 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.919 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.32 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.1 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 73.43 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 72.32 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 73.43 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.54 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.35 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.32 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.22 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.35 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.919 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 71.21 111.11 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.31 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 65.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.44 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.31 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 72.41 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -107.18 132.14 53.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 74.54 110.904 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 74.22 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.23 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.13 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.091 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.22 110.911 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.15 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.135 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.14 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.51 112.452 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.31 110.84 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.01 111.105 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.478 ' NE2' ' HB2' ' A' ' 7' ' ' LYS . 1.3 mm-40 -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.888 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 15.3 pt20 -100.45 -168.14 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.41 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.51 -23.93 61.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.863 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.435 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.9 mm-40 -49.97 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.98 -66.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 52.33 112.484 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 159.5 53.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 74.55 112.317 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.36 -177.47 3.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.841 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.52 151.35 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.22 111.112 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 71.05 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 74.42 111.157 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.878 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.14 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 71.14 111.089 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.11 111.133 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.73 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.904 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.12 175.52 9.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.0 111.077 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.26 74.33 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 72.53 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.99 143.54 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 62.31 112.5 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -54.79 111.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.33 110.851 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -156.05 163.64 39.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 73.43 110.892 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.3 p -116.67 -174.76 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 62.11 111.18 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.2 mt -109.06 163.64 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 75.51 110.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.92 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 71.3 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.24 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.149 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.53 110.919 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 75.22 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.43 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.14 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.53 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 64.1 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 75.53 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 74.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.22 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.21 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.55 111.084 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 75.14 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.1 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.13 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.879 0.371 . . . . 73.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.130000000000003 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 111.113 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.530000000000001 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.514 ' HE2' HD11 ' A' ' 33' ' ' ILE . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.92 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.019999999999996 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.349999999999994 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 55.439999999999998 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 35.43 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.430000000000007 110.91 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.119999999999997 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 61.32 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 110.913 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 70.519999999999996 111.103 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.310000000000002 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.135 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.874 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.856 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 30' ' ' PHE . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 111.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 71.25 110.909 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.804 0.335 . . . . 71.049999999999997 110.911 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 60.229999999999997 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' A' ' 6' ' ' VAL . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.439999999999998 110.893 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.140000000000001 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.219999999999999 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.823 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' HG22 ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.230000000000004 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.439999999999998 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.891 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.109999999999999 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 54.039999999999999 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.120000000000005 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.129999999999995 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.439999999999998 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.129999999999995 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.140000000000001 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.928 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 111.048 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 62.210000000000001 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 53.030000000000001 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 110.914 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.340000000000003 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.430000000000007 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.409999999999997 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.159 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HE2' ' NE2' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.92 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' HE2' HD11 ' A' ' 33' ' ' ILE . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 63.5 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 51.5 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 64.420000000000002 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.549999999999997 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.030000000000001 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 45.549999999999997 112.489 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.420000000000002 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 111.151 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.433 ' NE2' ' HE2' ' A' ' 7' ' ' LYS . 6.4 mm100 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 63.100000000000001 110.917 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.913 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 70.109999999999999 111.188 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 63.310000000000002 111.147 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.81 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.883 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 55.219999999999999 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.129999999999995 111.074 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.899 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.837 0.351 . . . . 74.299999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.852 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.340000000000003 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.530000000000001 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 63.329999999999998 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 26' ' ' VAL . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 110.929 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 70.129999999999995 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.57 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 72.019999999999996 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.310000000000002 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 62.149999999999999 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.120000000000005 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.109999999999999 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.340000000000003 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.811 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.737 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.095 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 60.109999999999999 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 54.549999999999997 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.737 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 62.25 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.119999999999997 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.140000000000001 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 72.319999999999993 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.349999999999994 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 63.200000000000003 111.126 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HE3' ' NE2' ' A' ' 19' ' ' GLN . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.867 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.61 ' CE1' HD11 ' A' ' 33' ' ' ILE . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 110.878 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.099999999999994 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 61.509999999999998 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 70.239999999999995 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 65.540000000000006 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.240000000000002 112.505 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.230000000000004 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 111.095 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.402 ' NE2' ' HE3' ' A' ' 7' ' ' LYS . 8.4 mm100 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 70.230000000000004 110.926 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 71.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.797 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 54.340000000000003 111.166 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.229999999999997 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.099999999999994 111.151 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.299999999999997 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.869 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 62.32 110.873 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 30' ' ' PHE . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.100000000000001 110.868 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.854 0.359 . . . . 53.509999999999998 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 65.420000000000002 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.239999999999995 110.919 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 61.219999999999999 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 55.229999999999997 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 63.509999999999998 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 63.219999999999999 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.62 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.219999999999999 110.848 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 42.219999999999999 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.319999999999993 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.109999999999999 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 54.119999999999997 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.349999999999994 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 61.219999999999999 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 61.439999999999998 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.099999999999994 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 64.439999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 65.120000000000005 111.063 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 63.310000000000002 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 52.340000000000003 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 62.420000000000002 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.825 0.345 . . . . 62.310000000000002 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.409999999999997 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.219999999999999 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 111.153 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CE1' HD11 ' A' ' 33' ' ' ILE . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 110.877 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.010000000000005 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.140000000000001 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 54.340000000000003 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.239999999999995 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.91 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 42.0 112.471 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 62.240000000000002 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.030000000000001 111.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.893 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.796 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.882 0.372 . . . . 70.400000000000006 111.118 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.101 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.853 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 73.019999999999996 110.908 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.450000000000003 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 111.125 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 111.138 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.009999999999998 110.864 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 47' ' ' VAL . 10.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.828 0.346 . . . . 75.109999999999999 110.941 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 60.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.653 ' HA ' HG13 ' A' ' 6' ' ' VAL . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.892 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.439999999999998 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 63.549999999999997 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 41' ' ' LEU . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.319999999999993 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.420000000000002 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 64.329999999999998 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.540000000000006 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.150000000000006 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 50.310000000000002 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.109999999999999 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 72.239999999999995 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.510000000000005 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.128 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.913 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 65.340000000000003 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 74.129999999999995 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 64.439999999999998 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 62.109999999999999 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HE2' ' NE2' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.854 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.84 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 50.329999999999998 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 61.329999999999998 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.67 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.109999999999999 112.493 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 71.120000000000005 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.855 HD12 HG11 ' A' ' 28' ' ' VAL . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.319999999999993 111.113 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.426 ' NE2' ' HE2' ' A' ' 7' ' ' LYS . 6.3 mm100 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.879 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.891 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 72.530000000000001 111.098 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' A' ' 62' ' ' ALA . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.120000000000005 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.731 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 64.040000000000006 110.846 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 111.092 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 30' ' ' PHE . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.093 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.91 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 47' ' ' VAL . 25.6 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.801 0.334 . . . . 74.329999999999998 110.91 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.868 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 50.240000000000002 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 62.240000000000002 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.439999999999998 110.861 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.340000000000003 111.152 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.646 ' O ' HG22 ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' A' ' 26' ' ' VAL . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.530000000000001 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 72.430000000000007 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.340000000000003 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.400000000000006 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.879 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.009999999999998 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 45.100000000000001 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 73.340000000000003 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.319999999999993 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.106 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 53.329999999999998 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 43.43 111.123 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.859 0.362 . . . . 71.530000000000001 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.510000000000005 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.200000000000003 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.121 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.763 ' CE1' HD13 ' A' ' 41' ' ' LEU . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.876 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 55.009999999999998 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.019999999999996 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.349999999999994 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 33.030000000000001 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 65.140000000000001 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 54.43 112.485 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 72.439999999999998 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.340000000000003 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.935 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 73.129999999999995 111.151 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 65.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 111.15 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.299999999999997 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.519999999999996 110.853 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 54.219999999999999 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 40.149999999999999 111.096 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 111.119 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.862 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.763 HD13 ' CE1' ' A' ' 9' ' ' PHE . 6.2 mp . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.817 0.341 . . . . 73.109999999999999 110.917 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 6' ' ' VAL . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 70.400000000000006 110.898 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.329999999999998 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 55.409999999999997 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG11 HD23 ' A' ' 41' ' ' LEU . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.12 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.439999999999998 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 26' ' ' VAL . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 62.25 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 64.450000000000003 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.911 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 43.43 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 72.019999999999996 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.030000000000001 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.519999999999996 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 71.400000000000006 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 71.400000000000006 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 55.439999999999998 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.911 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.310000000000002 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 60.520000000000003 111.114 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 70.129999999999995 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.768 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.019999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.884 0.373 . . . . 73.25 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.907 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.540000000000006 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 64.319999999999993 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.128 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 53.439999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.340000000000003 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 31.510000000000002 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 64.010000000000005 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.149999999999999 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' CD1' ' A' ' 49' ' ' PHE . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.139 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.911 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.120000000000005 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.68 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.872 0.368 . . . . 74.129999999999995 111.157 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 70.019999999999996 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 64.200000000000003 111.141 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 63.149999999999999 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HA ' HD12 ' A' ' 33' ' ' ILE . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.893 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.144 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 54.25 111.08 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.25 110.88 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 6' ' ' VAL . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 110.848 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 71.019999999999996 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.200000000000003 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.437 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 60.119999999999997 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.019999999999996 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.9 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.439999999999998 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 64.409999999999997 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.120000000000005 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 51.439999999999998 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 71.540000000000006 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 72.209999999999994 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 42.140000000000001 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.400000000000006 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.9 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 63.409999999999997 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.868 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.340000000000003 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 50.020000000000003 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.848 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.866 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 72.420000000000002 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 73.540000000000006 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 HD23 ' A' ' 41' ' ' LEU . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.229999999999997 111.105 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HE3' ' NE2' ' A' ' 19' ' ' GLN . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.88 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 33' ' ' ILE . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.826 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 54.219999999999999 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 44.020000000000003 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.129999999999995 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 44.140000000000001 112.466 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.510000000000005 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 111.161 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.4 ' NE2' ' HE3' ' A' ' 7' ' ' LYS . 9.2 mm100 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 63.539999999999999 110.912 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.941 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.846 0.355 . . . . 73.349999999999994 111.103 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.111 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.881 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.873 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 30' ' ' PHE . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 40.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.703 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.06 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 61.25 111.121 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.929 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD23 HG21 ' A' ' 6' ' ' VAL . 14.8 tp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.805 0.336 . . . . 62.210000000000001 110.954 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HA ' HG13 ' A' ' 6' ' ' VAL . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.9 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 44.030000000000001 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.329999999999998 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.25 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 41' ' ' LEU . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 64.329999999999998 111.133 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 26' ' ' VAL . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 64.299999999999997 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 71.319999999999993 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 63.520000000000003 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 54.130000000000003 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 61.409999999999997 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 51' ' ' VAL . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 63.409999999999997 112.367 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 63.210000000000001 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 111.067 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 74.140000000000001 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 61.399999999999999 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 51.43 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.209999999999994 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 33' ' ' ILE . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.150000000000006 110.841 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.519999999999996 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 64.409999999999997 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 61.140000000000001 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.439999999999998 112.544 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 111.134 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 110.853 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.177 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.450000000000003 111.131 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.887 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 55.299999999999997 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.869 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.811 0.338 . . . . 65.340000000000003 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 6' ' ' VAL . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.89 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 44.409999999999997 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.510000000000005 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.230000000000004 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.009999999999998 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' A' ' 26' ' ' VAL . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.539999999999999 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.030000000000001 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 54.210000000000001 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.430000000000007 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 44.399999999999999 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.219999999999999 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 54.420000000000002 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.140000000000001 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.450000000000003 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.43 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 64.420000000000002 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 63.350000000000001 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 61.119999999999997 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 63.329999999999998 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.420000000000002 111.135 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.528 ' HG3' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 33' ' ' ILE . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 53.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 54.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.340000000000003 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.310000000000002 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.340000000000003 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 26' ' ' VAL . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.106 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.528 HE22 ' HG3' ' A' ' 7' ' ' LYS . 11.9 pm0 -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.916 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.691 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.864 0.364 . . . . 74.319999999999993 111.152 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 111.158 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.807 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.81 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 61.340000000000003 111.118 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.349999999999994 111.11 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.904 179.934 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.879 0.371 . . . . 62.530000000000001 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.129999999999995 110.843 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.149999999999999 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.439999999999998 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 51.32 110.928 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 54.549999999999997 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.329999999999998 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.129999999999995 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.210000000000001 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 62.130000000000003 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 43.32 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.150000000000006 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.099999999999994 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.94 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.815 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.082 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.815 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 62.329999999999998 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.536 ' O ' HD13 ' A' ' 68' ' ' ILE . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 64.420000000000002 110.873 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 67' ' ' ARG . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.539999999999999 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.361 . . . . 60.520000000000003 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 22.219999999999999 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.049999999999997 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 111.104 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.669 ' CE2' HD23 ' A' ' 41' ' ' LEU . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.420000000000002 110.885 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.299999999999997 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 55.43 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.200000000000003 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.239999999999995 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.329999999999998 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' HB ' HG12 ' A' ' 26' ' ' VAL . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 53.399999999999999 111.12 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.129999999999995 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 110.867 -179.885 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 41.100000000000001 111.121 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 33' ' ' ILE . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 110.841 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.131 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 60.119999999999997 111.13 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.099999999999994 110.897 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.669 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.1 mm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.838 0.351 . . . . 64.150000000000006 110.949 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 6' ' ' VAL . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.210000000000001 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.400000000000006 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 41' ' ' LEU . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.183 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HG11 ' A' ' 26' ' ' VAL . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 62.520000000000003 110.84 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.019999999999996 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.942 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' H ' ' H ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 51.310000000000002 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.109999999999999 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 43.549999999999997 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 50.009999999999998 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 61.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 43.310000000000002 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.942 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.103 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 53.210000000000001 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.299999999999997 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.099999999999994 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 63.43 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 70.239999999999995 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.219999999999999 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 111.111 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.530000000000001 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 65.450000000000003 110.816 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.420000000000002 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.209999999999994 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 35.009999999999998 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 55.200000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' HG12 ' A' ' 26' ' ' VAL . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.510000000000005 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.915 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 64.420000000000002 111.149 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.209999999999994 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 111.156 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.868 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 61.329999999999998 110.861 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 62.119999999999997 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 30' ' ' PHE . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.148 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 53.310000000000002 110.891 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.854 0.359 . . . . 75.219999999999999 110.859 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.615 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.210000000000001 110.882 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.439999999999998 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.540000000000006 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 64.400000000000006 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD2' HG11 ' A' ' 26' ' ' VAL . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.853 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.240000000000002 110.866 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 63.409999999999997 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 41.399999999999999 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.140000000000001 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 71.510000000000005 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 54.329999999999998 111.075 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 64.099999999999994 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.842 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 64.340000000000003 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.030000000000001 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 71.010000000000005 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 43' ' ' GLU . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 61.329999999999998 111.142 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.907 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 41' ' ' LEU . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.120000000000005 110.885 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 55.149999999999999 111.099 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 52.539999999999999 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.109999999999999 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.109999999999999 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 31.399999999999999 112.482 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 49' ' ' PHE . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 12.9 pm0 -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.885 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.944 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.893 0.377 . . . . 44.119999999999997 111.115 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.136 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.329999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.88 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.079 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 30' ' ' PHE . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.120000000000005 111.13 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 62.149999999999999 110.936 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.918 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.530000000000001 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 63.25 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 18' ' ' ILE . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.917 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.319999999999993 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 44.149999999999999 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 55.530000000000001 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 41.25 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.239999999999995 110.905 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.049999999999997 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.439999999999998 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 71.329999999999998 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.450000000000003 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.540000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 111.122 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.439999999999998 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.767 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 61.310000000000002 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.841 0.353 . . . . 72.349999999999994 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.120000000000005 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 72.349999999999994 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 63.43 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.138 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.540000000000006 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.68 ' CD1' HD23 ' A' ' 41' ' ' LEU . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 110.878 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 50.119999999999997 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.310000000000002 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 62.119999999999997 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.329999999999998 112.516 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 53.210000000000001 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 45.100000000000001 111.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 72.109999999999999 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.89 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.868 0.366 . . . . 73.439999999999998 111.123 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HB3' HG22 ' A' ' 31' ' ' THR . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.88 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 110.889 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 29' ' ' HIS . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 53.130000000000003 111.149 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 52.119999999999997 111.095 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 111.128 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.858 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.68 HD23 ' CD1' ' A' ' 9' ' ' PHE . 2.8 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.844 0.354 . . . . 73.239999999999995 110.952 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 35.329999999999998 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 41' ' ' LEU . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.13 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 53.25 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 26' ' ' VAL . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.439999999999998 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.922 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 71.5 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 65.209999999999994 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 44.299999999999997 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 53.399999999999999 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.230000000000004 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 73.010000000000005 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.922 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 53.039999999999999 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.140000000000001 111.079 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.833 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.099999999999994 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' C ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.866 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 111.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.877 0.37 . . . . 74.340000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.120000000000005 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.019999999999996 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.652 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 111.103 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.872 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 41' ' ' LEU . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.885 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 62.039999999999999 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.540000000000006 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 54.539999999999999 110.866 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.030000000000001 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.040000000000006 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 111.066 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.010000000000005 110.911 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 61.530000000000001 110.959 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 74.329999999999998 111.107 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.049999999999997 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 111.096 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.853 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.864 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.049999999999997 110.866 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.092 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 30' ' ' PHE . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 111.15 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 54.409999999999997 110.876 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CE1' ' A' ' 9' ' ' PHE . 2.6 mm? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.866 0.365 . . . . 74.019999999999996 110.938 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 42.240000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.912 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.409999999999997 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.340000000000003 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.329999999999998 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.91 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 72.319999999999993 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.149999999999999 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.299999999999997 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.349999999999994 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 53.149999999999999 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.030000000000001 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.530000000000001 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.349999999999994 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.409999999999997 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.91 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.782 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.539999999999999 111.075 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.200000000000003 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.120000000000005 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.120000000000005 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 111.143 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 44.539999999999999 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.430000000000007 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 33' ' ' ILE . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.219999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.130000000000003 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.209999999999994 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.340000000000003 110.945 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.219999999999999 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.420000000000002 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.459 ' HB ' HG12 ' A' ' 26' ' ' VAL . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.127 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 61.119999999999997 110.934 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 110.878 -179.915 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 HG12 ' A' ' 51' ' ' VAL . 2.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.845 0.355 . . . . 53.509999999999998 111.118 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 64.299999999999997 111.14 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 37.4 m80 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.867 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.866 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 73.030000000000001 111.099 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.128 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.884 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.229 0.021 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 45.140000000000001 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.635 ' HA ' HG13 ' A' ' 6' ' ' VAL . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.879 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 44.210000000000001 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' O ' HG22 ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 26' ' ' VAL . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 70.430000000000007 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.129999999999995 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 73.349999999999994 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 73.420000000000002 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.299999999999997 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 70.129999999999995 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.329999999999998 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.430000000000007 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 71.299999999999997 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.817 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.030000000000001 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.85 0.357 . . . . 74.209999999999994 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.100000000000001 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 72.209999999999994 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.430000000000007 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.340000000000003 110.844 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.310000000000002 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 71.209999999999994 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.409999999999997 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.140000000000001 112.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.150000000000006 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.905 HD12 HG11 ' A' ' 28' ' ' VAL . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.450000000000003 111.162 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.92 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.933 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.8 0.333 . . . . 63.409999999999997 111.17 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.905 HG11 HD12 ' A' ' 18' ' ' ILE . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.126 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 111.146 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 70.420000000000002 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.827 0.346 . . . . 71.409999999999997 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.863 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.450000000000003 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.530000000000001 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.530000000000001 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 63.149999999999999 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.450000000000003 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 HG21 ' A' ' 26' ' ' VAL . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.349999999999994 110.908 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 43.329999999999998 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.119999999999997 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 64.319999999999993 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.530000000000001 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.349999999999994 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.340000000000003 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 53.130000000000003 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.823 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 111.095 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 65.140000000000001 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' C ' HG12 ' A' ' 68' ' ' ILE . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.510000000000005 110.811 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.405 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 64.450000000000003 110.866 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.210000000000001 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 111.107 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HE3' ' NE2' ' A' ' 19' ' ' GLN . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.87 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' HD11 ' A' ' 33' ' ' ILE . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.019999999999996 110.854 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 63.5 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.239999999999995 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.409999999999997 112.473 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 71.010000000000005 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.340000000000003 111.138 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' NE2' ' HE3' ' A' ' 7' ' ' LYS . 10.1 mm100 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.905 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 110.899 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.731 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 63.119999999999997 111.14 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 111.133 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB3' HG22 ' A' ' 31' ' ' THR . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.844 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.329999999999998 110.891 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' HIS . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.519999999999996 111.158 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 111.094 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 30' ' ' PHE . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.009999999999998 111.057 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 64.109999999999999 110.909 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 65.530000000000001 110.936 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 62.509999999999998 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HA ' HG13 ' A' ' 6' ' ' VAL . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.049999999999997 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 35.219999999999999 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 51.409999999999997 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.938 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.349999999999994 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.329999999999998 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 24.129999999999999 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 44.420000000000002 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.209999999999994 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 61.140000000000001 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.938 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 63.340000000000003 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.129999999999995 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 61.200000000000003 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 73.010000000000005 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.450000000000003 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.616 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 111.127 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.100000000000001 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.030000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HE2' HD11 ' A' ' 33' ' ' ILE . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 51.119999999999997 110.881 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 50.520000000000003 111.13 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 70.25 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.510000000000005 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.030000000000001 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 64.329999999999998 111.173 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 110.923 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.368 . . . . 74.219999999999999 111.138 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 60.420000000000002 111.143 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 55.200000000000003 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 70.439999999999998 110.865 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.450000000000003 111.117 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.420000000000002 111.145 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.430000000000007 110.853 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.23 0.033 0 CA-C-O 120.826 0.346 . . . . 74.519999999999996 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 61.009999999999998 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.616 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 110.884 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 31.34 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.109999999999999 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.5 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.010000000000005 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.099999999999994 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 70.150000000000006 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 63.049999999999997 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.540000000000006 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.349999999999994 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.319999999999993 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.219999999999999 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.349999999999994 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.933 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.230000000000004 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 51.509999999999998 111.11 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.310000000000002 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.795 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 64.299999999999997 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.837 0.351 . . . . 70.129999999999995 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 63.509999999999998 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.230000000000004 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.129999999999995 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 51.240000000000002 111.091 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.47 ' HE2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HE1' HD11 ' A' ' 33' ' ' ILE . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.911 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.150000000000006 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.135 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.140000000000001 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.510000000000005 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' VAL . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 110.84 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 55.450000000000003 111.105 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.47 ' NE2' ' HE2' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.888 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.929 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.704 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.822 0.344 . . . . 60.219999999999999 111.112 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.149999999999999 111.157 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.140000000000001 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 42.119999999999997 111.089 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 30' ' ' PHE . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 111.133 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.904 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 HG11 ' A' ' 47' ' ' VAL . 38.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 74.510000000000005 110.914 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 45.299999999999997 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 53.119999999999997 110.92 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 54.100000000000001 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.619 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.099999999999994 111.149 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 26' ' ' VAL . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 110.919 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 44.530000000000001 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.430000000000007 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.140000000000001 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 74.299999999999997 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.530000000000001 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 54.340000000000003 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 60.240000000000002 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 73.040000000000006 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.219999999999999 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.210000000000001 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.084 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 73.299999999999997 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.420000000000002 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.530000000000001 111.13 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 55.200000000000003 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -118.05 148.45 42.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 110.886 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.130000000000003 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 111.113 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.530000000000001 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.514 ' HE2' HD11 ' A' ' 33' ' ' ILE . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.92 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.019999999999996 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.349999999999994 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 55.439999999999998 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 35.43 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.430000000000007 110.91 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.119999999999997 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 61.32 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 6.3 pt20 -100.23 -172.31 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 110.913 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -60.17 -24.99 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 53.140000000000001 110.838 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 96.1 mt-10 -50.89 -75.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 73.030000000000001 110.887 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.81 -66.39 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 73.129999999999995 112.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 167.14 25.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 51.43 112.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.46 -175.6 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.846 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -136.26 152.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 70.519999999999996 111.103 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.310000000000002 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.135 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.874 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.856 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 30' ' ' PHE . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 111.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.35 89.88 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 71.25 110.909 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.04 172.22 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 52.140000000000001 111.098 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.83 76.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.856 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.88 -118.54 3.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -65.54 112.29 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 71.150000000000006 110.885 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HB2' HG21 ' A' ' 33' ' ' ILE . 15.5 ptt180 -99.96 49.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 65.209999999999994 110.858 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.8 m -118.47 135.21 54.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.122 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? -109.09 179.07 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 110.911 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 60.229999999999997 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' A' ' 6' ' ' VAL . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.439999999999998 110.893 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.140000000000001 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.219999999999999 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.823 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' HG22 ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.230000000000004 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.439999999999998 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.891 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.109999999999999 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 54.039999999999999 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.120000000000005 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.129999999999995 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.439999999999998 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.129999999999995 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.140000000000001 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.928 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 111.048 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 62.210000000000001 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 53.030000000000001 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.89 0.376 . . . . 44.439999999999998 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -130.34 145.13 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 72.109999999999999 110.914 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.340000000000003 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.430000000000007 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.409999999999997 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.159 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD3' ' HG3' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.92 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' HE2' HD11 ' A' ' 33' ' ' ILE . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 63.5 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 51.5 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 64.420000000000002 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.549999999999997 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.030000000000001 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 45.549999999999997 112.489 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.420000000000002 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 111.151 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 25.7 mm-40 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 63.100000000000001 110.917 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.23 -174.43 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.45 -24.66 65.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 44.409999999999997 110.926 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.99 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.209999999999994 110.888 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 -68.46 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.745 . . . . 64.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 165.74 29.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 63.240000000000002 112.362 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -80.32 -175.3 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.849 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -138.4 151.31 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 70.109999999999999 111.188 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 63.310000000000002 111.147 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.81 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.883 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 55.219999999999999 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.129999999999995 111.074 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.24 86.43 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.899 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 174.75 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.200000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.64 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 72.030000000000001 110.857 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.52 -147.96 17.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 54.229999999999997 112.467 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.05 111.85 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 64.310000000000002 110.895 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -64.55 101.76 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.25 110.838 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.47 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -152.5 135.98 16.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.152 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 40' ' ' THR . 11.0 mp -118.48 164.44 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 110.898 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.852 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.340000000000003 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.530000000000001 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 63.329999999999998 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 26' ' ' VAL . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 110.929 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 70.129999999999995 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.57 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 72.019999999999996 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.310000000000002 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 62.149999999999999 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.120000000000005 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.109999999999999 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.340000000000003 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.811 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.737 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.095 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 60.109999999999999 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 54.549999999999997 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.737 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 62.25 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.119999999999997 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.140000000000001 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 71.420000000000002 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -126.98 131.86 50.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 110.897 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.349999999999994 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 63.200000000000003 111.126 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.867 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.61 ' CE1' HD11 ' A' ' 33' ' ' ILE . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 110.878 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.099999999999994 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 61.509999999999998 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 70.239999999999995 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 65.540000000000006 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.240000000000002 112.505 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.230000000000004 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 111.095 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 70.230000000000004 110.926 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.0 -167.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 71.0 110.913 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.68 -27.15 68.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.872 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 3.2 mm-40 -48.87 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.463 . . . . 74.120000000000005 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.54 -66.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 60.340000000000003 112.504 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 165.81 29.66 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.639 2.226 . . . . 74.340000000000003 112.371 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.73 171.65 13.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 74.530000000000001 110.867 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.797 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -127.26 151.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 54.340000000000003 111.166 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.229999999999997 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.099999999999994 111.151 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.299999999999997 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.869 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 62.32 110.873 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 30' ' ' PHE . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -110.49 87.68 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.100000000000001 110.868 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.48 172.31 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 111.061 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.21 75.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.907 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.9 140.01 5.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.747 . . . . 64.049999999999997 112.478 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -54.03 110.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 52.409999999999997 110.908 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -152.67 179.3 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 53.399999999999999 110.877 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -132.48 -178.55 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 63.350000000000001 111.166 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.3 mm? -110.14 176.83 4.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 53.509999999999998 110.896 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 65.420000000000002 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.239999999999995 110.919 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 61.219999999999999 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 55.229999999999997 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 63.509999999999998 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 63.219999999999999 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.62 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.219999999999999 110.848 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 42.219999999999999 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.319999999999993 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.109999999999999 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 54.119999999999997 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.349999999999994 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 61.219999999999999 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 61.439999999999998 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.099999999999994 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 64.439999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 65.120000000000005 111.063 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 63.310000000000002 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 52.340000000000003 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 62.420000000000002 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 73.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -130.47 155.4 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 62.310000000000002 110.887 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.409999999999997 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.219999999999999 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 111.153 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CE1' HD11 ' A' ' 33' ' ' ILE . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 110.877 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.010000000000005 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.140000000000001 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 54.340000000000003 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.239999999999995 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.91 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 42.0 112.471 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 62.240000000000002 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.030000000000001 111.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 -166.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.893 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -69.12 -27.65 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.13 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 110.913 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -66.5 0.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.689 -0.767 . . . . 64.439999999999998 112.431 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 164.12 35.75 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.721 2.281 . . . . 51.520000000000003 112.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.94 -169.85 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 75.329999999999998 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.796 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -146.41 151.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.118 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.101 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.853 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 73.019999999999996 110.908 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.450000000000003 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 111.125 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 111.138 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.35 93.39 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.009999999999998 110.864 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -137.74 179.08 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 70.409999999999997 111.136 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.53 77.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.219999999999999 110.858 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.12 -117.82 3.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -70.99 110.04 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 74.030000000000001 110.885 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HG3' ' HB3' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -88.78 58.11 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.895 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -121.45 138.5 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 73.219999999999999 111.171 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 47' ' ' VAL . 10.1 mt -109.26 169.56 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.109999999999999 110.941 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 60.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.653 ' HA ' HG13 ' A' ' 6' ' ' VAL . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.892 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.439999999999998 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 63.549999999999997 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 41' ' ' LEU . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.319999999999993 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.420000000000002 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 64.329999999999998 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.540000000000006 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.150000000000006 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 50.310000000000002 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.109999999999999 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 72.239999999999995 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.510000000000005 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.128 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.913 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.867 0.365 . . . . 53.530000000000001 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -118.13 145.61 44.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.893 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 74.129999999999995 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 64.439999999999998 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 62.109999999999999 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.854 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.442 ' HE2' ' HG1' ' A' ' 40' ' ' THR . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.84 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 50.329999999999998 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 61.329999999999998 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.109999999999999 112.493 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 71.120000000000005 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.855 HD12 HG11 ' A' ' 28' ' ' VAL . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.319999999999993 111.113 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.879 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.79 175.31 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.41 -23.21 14.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 71.109999999999999 110.905 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.55 -72.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.832 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.9 -69.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 166.12 28.75 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 70.519999999999996 112.329 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.42 -173.26 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 110.881 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -143.48 151.75 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 111.098 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' A' ' 62' ' ' ALA . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.120000000000005 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.731 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 64.040000000000006 110.846 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 111.092 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 30' ' ' PHE . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.093 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.93 92.01 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.91 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.43 168.31 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.094 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.24 74.4 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.87 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.91 163.23 11.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 53.210000000000001 112.523 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -55.66 110.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 55.229999999999997 110.922 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -142.8 -173.79 3.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.898 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.442 ' HG1' ' HE2' ' A' ' 9' ' ' PHE . 13.5 t -162.96 174.62 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 70.219999999999999 111.165 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 47' ' ' VAL . 25.6 mt -108.99 159.84 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 74.329999999999998 110.91 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.868 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 50.240000000000002 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 62.240000000000002 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.439999999999998 110.861 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.340000000000003 111.152 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.646 ' O ' HG22 ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' A' ' 26' ' ' VAL . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.530000000000001 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 72.430000000000007 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.340000000000003 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.400000000000006 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.879 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.009999999999998 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 45.100000000000001 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 73.340000000000003 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.319999999999993 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.106 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 53.329999999999998 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 43.43 111.123 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.894 0.378 . . . . 73.540000000000006 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -111.75 129.45 56.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 71.530000000000001 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.510000000000005 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.200000000000003 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.121 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' CE1' HD13 ' A' ' 41' ' ' LEU . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.876 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 55.009999999999998 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.019999999999996 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.349999999999994 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 33.030000000000001 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 65.140000000000001 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 54.43 112.485 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 72.439999999999998 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.340000000000003 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.84 -168.24 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.935 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.03 -29.14 70.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.229999999999997 110.889 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -46.86 -72.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.899 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.48 -66.7 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 71.420000000000002 112.493 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 164.54 34.16 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 75.319999999999993 112.304 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -178.87 6.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -136.57 151.12 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 111.151 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 65.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 111.15 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.299999999999997 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.519999999999996 110.853 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 54.219999999999999 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 40.149999999999999 111.096 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 111.119 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -105.51 90.76 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.862 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . . . -133.44 170.38 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 62.329999999999998 111.109 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 78.24 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 63.539999999999999 110.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.76 -117.58 3.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 60.100000000000001 112.489 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -82.26 110.87 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 72.099999999999994 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.559 ' HB2' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.54 122.98 46.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 110.919 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -160.0 134.9 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 111.134 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.763 HD13 ' CE1' ' A' ' 9' ' ' PHE . 6.2 mp -109.14 158.26 17.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.917 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 6' ' ' VAL . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 70.400000000000006 110.898 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.329999999999998 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 55.409999999999997 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG11 HD23 ' A' ' 41' ' ' LEU . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.12 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.439999999999998 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 26' ' ' VAL . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 62.25 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 64.450000000000003 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.911 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 43.43 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 72.019999999999996 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.030000000000001 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.519999999999996 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 71.400000000000006 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 71.400000000000006 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 55.439999999999998 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.911 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.310000000000002 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 60.520000000000003 111.114 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 70.129999999999995 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.768 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.019999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.855 0.36 . . . . 73.430000000000007 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -118.76 149.7 41.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.882 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.907 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.540000000000006 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 64.319999999999993 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.128 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 53.439999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.340000000000003 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 31.510000000000002 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 64.010000000000005 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.149999999999999 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' CD1' ' A' ' 49' ' ' PHE . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.139 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.911 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.48 -179.12 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.120000000000005 110.926 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -21.52 23.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.858 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.16 -73.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.71 -68.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 63.109999999999999 112.52 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 168.14 22.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 53.130000000000003 112.369 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.0 172.88 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 52.32 110.898 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.68 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.83 150.75 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 70.019999999999996 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 64.200000000000003 111.141 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 63.149999999999999 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HA ' HD12 ' A' ' 33' ' ' ILE . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.893 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.144 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 54.25 111.08 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -112.84 85.8 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.25 110.88 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -112.47 177.72 4.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.530000000000001 111.092 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.4 74.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.832 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.65 -117.59 3.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 75.010000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -87.81 110.07 20.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 64.109999999999999 110.873 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 30.6 mtm180 -77.03 125.82 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.140000000000001 110.839 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -166.28 122.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 72.200000000000003 111.172 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt -108.87 -178.03 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 64.420000000000002 110.93 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 6' ' ' VAL . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 110.848 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 71.019999999999996 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.200000000000003 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.437 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 60.119999999999997 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.019999999999996 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.9 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.439999999999998 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 64.409999999999997 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.120000000000005 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 51.439999999999998 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 71.540000000000006 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 72.209999999999994 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 42.140000000000001 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.400000000000006 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.9 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 63.409999999999997 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.868 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.340000000000003 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 50.020000000000003 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.848 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -110.99 128.89 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 110.872 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.866 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 72.420000000000002 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 73.540000000000006 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 HD23 ' A' ' 41' ' ' LEU . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.229999999999997 111.105 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.88 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 33' ' ' ILE . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.826 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 54.219999999999999 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 44.020000000000003 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.129999999999995 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 44.140000000000001 112.466 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.510000000000005 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 111.161 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 63.539999999999999 110.912 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 12.1 pt20 -106.25 -169.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.941 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.06 -26.11 66.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.530000000000001 110.842 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 13.6 mm-40 -49.77 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.898 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.64 -66.48 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 65.140000000000001 112.498 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 165.64 30.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.652 2.235 . . . . 64.329999999999998 112.336 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.77 178.0 8.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.530000000000001 110.891 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -133.83 151.07 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.103 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.111 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.881 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.873 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 30' ' ' PHE . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 40.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.703 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.06 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 61.25 111.121 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -105.79 92.09 4.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.929 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.3 171.94 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 55.219999999999999 111.125 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.03 74.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.200000000000003 110.867 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.87 138.05 5.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 72.530000000000001 112.468 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -52.54 124.83 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.899 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.34 129.19 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.86 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.5 t -81.01 174.65 11.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.010000000000005 111.13 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD23 HG21 ' A' ' 6' ' ' VAL . 14.8 tp -109.61 168.18 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 62.210000000000001 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HA ' HG13 ' A' ' 6' ' ' VAL . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.9 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 44.030000000000001 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.329999999999998 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.25 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 41' ' ' LEU . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 64.329999999999998 111.133 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 26' ' ' VAL . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 64.299999999999997 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 71.319999999999993 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 63.520000000000003 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 54.130000000000003 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 61.409999999999997 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 51' ' ' VAL . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 63.409999999999997 112.367 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 63.210000000000001 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 111.067 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 74.140000000000001 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 61.399999999999999 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 62.549999999999997 110.891 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -121.66 149.85 42.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 63.420000000000002 110.892 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 51.43 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.209999999999994 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 33' ' ' ILE . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.150000000000006 110.841 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.519999999999996 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 64.409999999999997 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 61.140000000000001 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.439999999999998 112.544 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 111.134 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -105.17 -172.0 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 110.853 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -22.29 61.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 43.149999999999999 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -54.61 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 31.32 110.892 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.24 -67.94 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 43.020000000000003 112.517 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.3 35.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.218 . . . . 53.340000000000003 112.354 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -82.29 -173.71 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 64.209999999999994 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -139.8 151.55 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 111.177 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.450000000000003 111.131 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.887 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 55.299999999999997 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -108.76 91.63 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.53 -179.58 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 111.064 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.48 74.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 65.25 110.843 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 139.83 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 64.0 112.49 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -53.31 110.31 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.868 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -159.82 166.81 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 110.825 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.3 p -115.79 -173.88 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.147 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 165.6 11.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.966 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 6' ' ' VAL . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.89 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 44.409999999999997 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.510000000000005 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.230000000000004 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.009999999999998 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' A' ' 26' ' ' VAL . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.539999999999999 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.030000000000001 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 54.210000000000001 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.430000000000007 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 44.399999999999999 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.219999999999999 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 54.420000000000002 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.140000000000001 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.450000000000003 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.43 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 64.420000000000002 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 63.350000000000001 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.848 0.356 . . . . 64.430000000000007 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -122.88 152.54 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 110.897 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 61.119999999999997 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 63.329999999999998 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.420000000000002 111.135 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' HG3' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 33' ' ' ILE . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 53.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 54.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.340000000000003 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.310000000000002 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.340000000000003 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 26' ' ' VAL . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.106 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.528 HE22 ' HG3' ' A' ' 7' ' ' LYS . 11.9 pm0 -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.37 -169.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.916 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -84.04 -20.59 32.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.439999999999998 110.859 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -132.65 77.39 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.871 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 74.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 53.5 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 19' ' ' GLN . 53.8 Cg_endo -69.8 164.41 34.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 74.209999999999994 112.346 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.3 91.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.849 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.691 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -116.05 147.29 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 111.152 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 111.158 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.807 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.81 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 61.340000000000003 111.118 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.349999999999994 111.11 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.83 86.23 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.12 174.88 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 53.310000000000002 111.129 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.76 76.66 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.879 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.87 -117.93 3.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 72.25 112.503 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -67.92 110.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 75.400000000000006 110.907 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -85.82 89.83 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.010000000000005 110.883 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -158.07 145.88 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 52.43 111.122 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.72 166.19 12.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 62.530000000000001 110.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.129999999999995 110.843 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.149999999999999 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.439999999999998 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 51.32 110.928 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 54.549999999999997 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.329999999999998 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.129999999999995 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.210000000000001 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 62.130000000000003 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 43.32 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.150000000000006 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.099999999999994 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.94 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.815 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.082 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.815 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 62.329999999999998 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.536 ' O ' HD13 ' A' ' 68' ' ' ILE . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 64.420000000000002 110.873 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 67' ' ' ARG . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.539999999999999 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.815 0.34 . . . . 72.25 110.903 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -118.16 152.93 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 60.520000000000003 110.914 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 22.219999999999999 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.049999999999997 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 111.104 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.669 ' CE2' HD23 ' A' ' 41' ' ' LEU . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.420000000000002 110.885 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.299999999999997 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 55.43 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.200000000000003 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.239999999999995 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.329999999999998 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' HB ' HG12 ' A' ' 26' ' ' VAL . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 53.399999999999999 111.12 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.129999999999995 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -115.2 -168.16 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 110.867 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.62 -23.17 29.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 64.549999999999997 110.869 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -138.66 79.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 62.140000000000001 110.837 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 68.29 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 52.350000000000001 112.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 175.39 8.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 50.219999999999999 112.354 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.16 73.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 110.87 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -98.44 146.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 75.349999999999994 111.1 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 41.100000000000001 111.121 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 33' ' ' ILE . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 110.841 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.131 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 60.119999999999997 111.13 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -112.04 94.14 4.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.099999999999994 110.897 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.07 179.28 6.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 44.539999999999999 111.073 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -99.68 74.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 65.439999999999998 110.884 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.68 127.97 3.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 61.32 112.489 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -52.6 111.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 110.917 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.61 -169.45 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.927 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -128.26 179.04 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 111.111 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.669 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.1 mm? -108.69 163.76 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.949 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 6' ' ' VAL . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.210000000000001 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.400000000000006 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 41' ' ' LEU . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.183 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HG11 ' A' ' 26' ' ' VAL . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 62.520000000000003 110.84 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.019999999999996 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.942 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' H ' ' H ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 51.310000000000002 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.109999999999999 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 43.549999999999997 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 50.009999999999998 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 61.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 43.310000000000002 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.942 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.103 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 53.210000000000001 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.299999999999997 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.099999999999994 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 63.43 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 70.239999999999995 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.834 0.349 . . . . 62.32 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -108.63 172.15 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.881 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.219999999999999 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 111.111 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.530000000000001 110.904 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 65.450000000000003 110.816 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.420000000000002 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.209999999999994 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 35.009999999999998 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 55.200000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' HG12 ' A' ' 26' ' ' VAL . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.510000000000005 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.437 ' NE2' ' HG2' ' A' ' 21' ' ' GLU . 2.9 tm0? -130.57 173.99 10.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.915 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG2' ' NE2' ' A' ' 20' ' ' GLN . 1.2 pt-20 -70.37 -16.11 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.219999999999999 110.935 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -137.6 76.79 1.6 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 71.340000000000003 110.896 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.66 72.21 0.51 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.762 . . . . 24.32 112.503 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 166.22 28.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 74.109999999999999 112.36 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.35 81.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 54.329999999999998 110.879 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -102.06 151.15 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.420000000000002 111.149 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.209999999999994 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 111.156 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.868 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 61.329999999999998 110.861 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 62.119999999999997 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 30' ' ' PHE . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.148 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -99.95 87.86 3.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 53.310000000000002 110.891 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.37 166.38 23.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 111.102 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.65 74.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.439999999999998 110.888 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.78 -159.34 17.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 61.399999999999999 112.514 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -96.67 111.06 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 73.140000000000001 110.85 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.45 110.36 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 110.85 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.2 p -79.73 -175.7 5.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 64.140000000000001 111.16 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? -110.0 169.3 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.859 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.615 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.210000000000001 110.882 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.439999999999998 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.540000000000006 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 64.400000000000006 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD2' HG11 ' A' ' 26' ' ' VAL . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.853 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.240000000000002 110.866 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 63.409999999999997 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 41.399999999999999 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.140000000000001 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 71.510000000000005 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 54.329999999999998 111.075 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 64.099999999999994 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.842 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.788 0.328 . . . . 65.209999999999994 110.886 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -101.47 170.96 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 64.340000000000003 110.874 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.030000000000001 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 71.010000000000005 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 43' ' ' GLU . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 61.329999999999998 111.142 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.907 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 41' ' ' LEU . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.120000000000005 110.885 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 40' ' ' THR . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 55.149999999999999 111.099 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 52.539999999999999 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.109999999999999 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.109999999999999 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 31.399999999999999 112.482 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 49' ' ' PHE . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 12.9 pm0 -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.885 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -108.62 -175.61 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.944 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.49 -21.35 62.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 62.299999999999997 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -52.74 -72.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.109999999999999 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.23 -68.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.742 . . . . 71.420000000000002 112.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 168.78 20.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 65.109999999999999 112.397 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -89.2 177.43 6.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.219999999999999 110.862 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -127.89 151.53 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 44.119999999999997 111.115 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.136 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.329999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.88 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.079 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 30' ' ' PHE . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.120000000000005 111.13 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -112.1 86.56 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.72 -179.94 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 61.130000000000003 111.061 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.2 74.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 73.519999999999996 110.828 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.69 139.38 5.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 72.349999999999994 112.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -52.57 110.09 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.859 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -169.88 165.83 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 70.239999999999995 110.866 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.579 HG21 ' HB2' ' A' ' 11' ' ' ALA . 47.5 p -115.85 -175.28 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 44.43 111.191 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -108.95 179.25 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.428 . . . . 62.149999999999999 110.936 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.918 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.530000000000001 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 63.25 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 18' ' ' ILE . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.917 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.319999999999993 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 44.149999999999999 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 55.530000000000001 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 41.25 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.239999999999995 110.905 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.049999999999997 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.439999999999998 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 71.329999999999998 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.450000000000003 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.540000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 111.122 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.439999999999998 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.5 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.767 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 61.310000000000002 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' H1 ' ' HB2' ' A' ' 50' ' ' GLU . 1.6 tpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 62.329999999999998 110.881 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.1 145.97 48.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.878 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.120000000000005 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 72.349999999999994 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 63.43 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.138 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.540000000000006 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.68 ' CD1' HD23 ' A' ' 41' ' ' LEU . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 110.878 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 50.119999999999997 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.310000000000002 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 62.119999999999997 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.329999999999998 112.516 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 53.210000000000001 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 45.100000000000001 111.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 72.109999999999999 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 3.1 pt20 -105.42 -168.69 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.89 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.51 -26.97 62.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 110.874 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 4.4 mm-40 -48.55 -74.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 63.100000000000001 110.943 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.81 -65.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 52.109999999999999 112.447 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.691 2.261 . . . . 70.430000000000007 112.37 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 169.66 17.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 110.876 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -128.19 151.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 111.123 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HB3' HG22 ' A' ' 31' ' ' THR . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.88 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 110.889 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 29' ' ' HIS . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 53.130000000000003 111.149 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 52.119999999999997 111.095 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 111.128 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.23 86.78 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.858 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.91 163.79 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 111.088 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.08 74.37 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.450000000000003 110.835 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.86 -162.35 15.65 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.801 -0.714 . . . . 74.340000000000003 112.489 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -96.53 130.58 43.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 74.299999999999997 110.847 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.95 -178.78 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.878 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.5 p -139.37 -174.61 3.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 111.117 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.68 HD23 ' CD1' ' A' ' 9' ' ' PHE . 2.8 mm? -109.18 164.88 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.952 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 35.329999999999998 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 41' ' ' LEU . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.13 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 53.25 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 26' ' ' VAL . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.439999999999998 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.922 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 71.5 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 65.209999999999994 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 44.299999999999997 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 53.399999999999999 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.230000000000004 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 73.010000000000005 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.922 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 53.039999999999999 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.140000000000001 111.079 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.833 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.099999999999994 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' C ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.866 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 111.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 63.420000000000002 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -108.79 163.4 13.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.856 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.120000000000005 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.019999999999996 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.652 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 111.103 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.872 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 41' ' ' LEU . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.885 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 62.039999999999999 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.540000000000006 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 54.539999999999999 110.866 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.030000000000001 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.040000000000006 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 111.066 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.010000000000005 110.911 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -101.25 -174.47 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 61.530000000000001 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.65 -23.44 66.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 74.219999999999999 110.851 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.91 -69.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.874 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.7 -68.1 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 61.340000000000003 112.493 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.42 21.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.324 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -88.27 -176.48 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.902 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -133.63 151.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 111.107 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.049999999999997 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 111.096 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.853 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.864 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.049999999999997 110.866 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.092 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 30' ' ' PHE . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 111.15 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.14 89.23 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 54.409999999999997 110.876 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.2 174.52 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 55.229999999999997 111.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.29 76.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 110.848 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.02 -154.69 16.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 64.409999999999997 112.5 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.62 116.03 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 74.049999999999997 110.91 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -154.8 169.21 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.881 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.4 p -149.39 175.22 11.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.144 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CE1' ' A' ' 9' ' ' PHE . 2.6 mm? -109.05 169.05 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 74.019999999999996 110.938 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 42.240000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.912 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.409999999999997 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.340000000000003 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.329999999999998 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.91 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 72.319999999999993 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.149999999999999 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.299999999999997 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.349999999999994 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 53.149999999999999 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.030000000000001 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.530000000000001 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.349999999999994 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.409999999999997 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.91 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.782 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.539999999999999 111.075 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.200000000000003 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.120000000000005 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' H1 ' ' HA ' ' A' ' 50' ' ' GLU . 3.1 ttt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 74.239999999999995 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -114.96 141.55 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 74.420000000000002 110.866 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.120000000000005 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 111.143 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 44.539999999999999 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.430000000000007 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 33' ' ' ILE . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.219999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.130000000000003 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.209999999999994 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.340000000000003 110.945 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.219999999999999 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.420000000000002 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.459 ' HB ' HG12 ' A' ' 26' ' ' VAL . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.127 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 61.119999999999997 110.934 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -112.66 -171.39 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 110.878 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -84.23 -18.68 35.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 61.119999999999997 110.899 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.36 78.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 61.140000000000001 110.871 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 73.69 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 74.450000000000003 112.457 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' GLN . 53.8 Cg_endo -69.78 163.2 39.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 72.319999999999993 112.371 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.24 88.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 65.409999999999997 110.891 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 HG12 ' A' ' 51' ' ' VAL . 2.3 p -114.29 149.46 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 53.509999999999998 111.118 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 64.299999999999997 111.14 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 37.4 m80 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.867 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.866 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 73.030000000000001 111.099 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.128 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.37 86.78 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.884 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.85 169.3 16.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 53.009999999999998 111.097 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.43 74.48 3.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 65.230000000000004 110.852 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.6 139.42 5.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 60.439999999999998 112.49 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -52.59 110.32 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.549999999999997 110.89 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -138.29 -170.14 2.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 110.838 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -143.26 174.47 10.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 111.166 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.01 163.4 13.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 110.924 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 45.140000000000001 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.635 ' HA ' HG13 ' A' ' 6' ' ' VAL . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.879 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 44.210000000000001 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' O ' HG22 ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 26' ' ' VAL . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 70.430000000000007 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.129999999999995 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 73.349999999999994 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 73.420000000000002 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.299999999999997 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 70.129999999999995 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.329999999999998 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.430000000000007 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 71.299999999999997 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.817 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.030000000000001 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.852 0.358 . . . . 70.450000000000003 110.901 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -146.83 159.34 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.896 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.100000000000001 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 72.209999999999994 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.430000000000007 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.340000000000003 110.844 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.310000000000002 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 71.209999999999994 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.409999999999997 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.140000000000001 112.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.150000000000006 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.905 HD12 HG11 ' A' ' 28' ' ' VAL . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.450000000000003 111.162 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -95.05 -169.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.92 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.01 -18.56 47.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 64.329999999999998 110.932 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -55.73 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.885 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.44 -65.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 62.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.39 27.8 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 73.140000000000001 112.357 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 -173.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 45.310000000000002 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.933 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -139.9 152.26 22.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.905 HG11 HD12 ' A' ' 18' ' ' ILE . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.126 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 111.146 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 70.420000000000002 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -112.02 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.26 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 111.072 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.66 76.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 64.140000000000001 110.834 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.67 -121.1 4.24 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.756 -0.735 . . . . 74.549999999999997 112.498 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -55.14 110.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 62.32 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.75 45.72 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 65.230000000000004 110.869 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -121.21 142.56 49.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 111.123 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.0 mm? -111.96 175.88 5.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.943 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.863 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.450000000000003 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.530000000000001 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.530000000000001 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 63.149999999999999 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.450000000000003 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 HG21 ' A' ' 26' ' ' VAL . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.349999999999994 110.908 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 43.329999999999998 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.119999999999997 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 64.319999999999993 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.530000000000001 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.349999999999994 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.340000000000003 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 53.130000000000003 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.823 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 111.095 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 65.140000000000001 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' C ' HG12 ' A' ' 68' ' ' ILE . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.510000000000005 110.811 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.405 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.869 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.9 150.34 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.450000000000003 110.866 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.210000000000001 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 111.107 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.87 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' HD11 ' A' ' 33' ' ' ILE . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.019999999999996 110.854 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 63.5 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.239999999999995 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.409999999999997 112.473 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 71.010000000000005 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.340000000000003 111.138 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.905 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -107.13 -171.81 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 110.899 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.45 -23.81 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -52.67 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.109999999999999 110.868 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.23 -66.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.458 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 164.71 33.46 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.209999999999994 112.384 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.44 -174.09 4.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 110.874 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.731 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -139.83 151.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 111.14 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 111.133 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB3' HG22 ' A' ' 31' ' ' THR . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.844 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.329999999999998 110.891 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' HIS . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.519999999999996 111.158 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 111.094 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 30' ' ' PHE . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.009999999999998 111.057 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.99 89.53 3.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 64.109999999999999 110.909 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.5 176.89 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 111.066 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.17 76.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 75.439999999999998 110.878 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.56 -137.2 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.340000000000003 112.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.98 110.11 6.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 72.400000000000006 110.88 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.4 mtm-85 -75.27 127.03 32.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.912 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -166.46 131.19 2.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.141 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp -114.32 164.05 14.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 65.530000000000001 110.936 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 62.509999999999998 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HA ' HG13 ' A' ' 6' ' ' VAL . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.049999999999997 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 35.219999999999999 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 51.409999999999997 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.938 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.349999999999994 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.329999999999998 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 24.129999999999999 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 44.420000000000002 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.209999999999994 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 61.140000000000001 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.938 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 63.340000000000003 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.129999999999995 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 61.200000000000003 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 63.240000000000002 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -141.65 138.35 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 110.894 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.450000000000003 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.616 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 111.127 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.100000000000001 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.030000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HE2' HD11 ' A' ' 33' ' ' ILE . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 51.119999999999997 110.881 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 40' ' ' THR . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 50.520000000000003 111.13 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 70.25 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.510000000000005 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.030000000000001 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 64.329999999999998 111.173 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -96.53 -169.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 110.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.56 -23.7 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.888 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.2 mm-40 -51.3 -70.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 72.209999999999994 110.887 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.55 -66.9 0.24 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 73.129999999999995 112.527 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 165.9 29.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.248 . . . . 72.450000000000003 112.325 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.66 -174.87 5.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 110.845 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -138.47 151.59 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.138 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 60.420000000000002 111.143 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 55.200000000000003 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 70.439999999999998 110.865 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.450000000000003 111.117 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.420000000000002 111.145 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.35 89.32 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.430000000000007 110.853 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.7 175.74 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 45.350000000000001 111.116 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -102.0 74.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.913 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.66 132.84 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 63.409999999999997 112.476 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -52.69 110.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 110.851 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -146.87 -169.7 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 74.329999999999998 110.891 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 13.4 t -134.71 177.02 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 111.126 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt -108.85 163.55 13.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 61.009999999999998 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.616 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 110.884 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 31.34 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.109999999999999 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.5 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.010000000000005 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.099999999999994 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 70.150000000000006 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 63.049999999999997 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.540000000000006 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.349999999999994 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.319999999999993 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.219999999999999 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.349999999999994 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.933 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.230000000000004 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 51.509999999999998 111.11 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.310000000000002 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.795 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 64.299999999999997 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H3 ' ' HA ' ' A' ' 50' ' ' GLU . 5.8 ttm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.889 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -107.18 132.14 53.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 70.129999999999995 110.904 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 63.509999999999998 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.230000000000004 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.129999999999995 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 51.240000000000002 111.091 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HE1' HD11 ' A' ' 33' ' ' ILE . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.911 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.150000000000006 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' CB ' HG21 ' A' ' 40' ' ' THR . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.135 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.140000000000001 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.510000000000005 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' VAL . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 110.84 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 55.450000000000003 111.105 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 7' ' ' LYS . 1.3 mm-40 -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.888 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 15.3 pt20 -100.45 -168.14 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.51 -23.93 61.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.863 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.9 mm-40 -49.97 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.98 -66.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 33.210000000000001 112.484 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 159.5 53.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 72.430000000000007 112.317 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.36 -177.47 3.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 70.219999999999999 110.841 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.704 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -139.52 151.35 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 111.112 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.149999999999999 111.157 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.140000000000001 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 42.119999999999997 111.089 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 30' ' ' PHE . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 111.133 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.73 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.904 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.12 175.52 9.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.0 111.077 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.26 74.33 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 72.439999999999998 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.99 143.54 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 62.310000000000002 112.5 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -54.79 111.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.851 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -156.05 163.64 39.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 73.430000000000007 110.892 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.405 HG21 ' CB ' ' A' ' 11' ' ' ALA . 68.3 p -116.67 -174.76 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 111.18 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 HG11 ' A' ' 47' ' ' VAL . 38.2 mt -109.06 163.64 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 45.299999999999997 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 53.119999999999997 110.92 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 54.100000000000001 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.619 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.099999999999994 111.149 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 26' ' ' VAL . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 110.919 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 44.530000000000001 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.430000000000007 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.140000000000001 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 74.299999999999997 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.530000000000001 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 54.340000000000003 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 60.240000000000002 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 73.040000000000006 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.219999999999999 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.210000000000001 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.084 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 73.299999999999997 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.420000000000002 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.530000000000001 111.13 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.879 0.371 . . . . 73.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.130000000000003 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 111.113 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.530000000000001 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.514 ' HE2' HD11 ' A' ' 33' ' ' ILE . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.92 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.019999999999996 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.349999999999994 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 55.439999999999998 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 35.43 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.430000000000007 110.91 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.119999999999997 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 61.32 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 110.913 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 70.519999999999996 111.103 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.310000000000002 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.135 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.874 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.856 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 30' ' ' PHE . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 111.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 71.25 110.909 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.804 0.335 . . . . 71.049999999999997 110.911 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 60.229999999999997 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' A' ' 6' ' ' VAL . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.439999999999998 110.893 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.140000000000001 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.219999999999999 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.823 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' HG22 ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.230000000000004 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.439999999999998 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.891 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.109999999999999 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 54.039999999999999 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.120000000000005 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.129999999999995 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.439999999999998 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.129999999999995 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.140000000000001 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.928 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 111.048 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 62.210000000000001 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 53.030000000000001 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 110.914 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.340000000000003 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.430000000000007 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.409999999999997 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.159 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD3' ' HG3' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.92 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' HE2' HD11 ' A' ' 33' ' ' ILE . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 63.5 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 51.5 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 64.420000000000002 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.549999999999997 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.030000000000001 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 45.549999999999997 112.489 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.420000000000002 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 111.151 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 25.7 mm-40 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 63.100000000000001 110.917 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.913 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 70.109999999999999 111.188 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 63.310000000000002 111.147 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.81 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.883 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 55.219999999999999 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.129999999999995 111.074 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.899 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.837 0.351 . . . . 74.299999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.852 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.340000000000003 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.530000000000001 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 63.329999999999998 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 26' ' ' VAL . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 110.929 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 70.129999999999995 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.57 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 72.019999999999996 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.310000000000002 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 62.149999999999999 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.120000000000005 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.109999999999999 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.340000000000003 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.811 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.737 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.095 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 60.109999999999999 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 54.549999999999997 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.737 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 62.25 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.119999999999997 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.140000000000001 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 72.319999999999993 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.349999999999994 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 63.200000000000003 111.126 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.867 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.61 ' CE1' HD11 ' A' ' 33' ' ' ILE . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 110.878 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.099999999999994 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 61.509999999999998 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 70.239999999999995 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 65.540000000000006 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.240000000000002 112.505 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.230000000000004 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 111.095 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 70.230000000000004 110.926 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 71.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.797 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.857 0.36 . . . . 54.340000000000003 111.166 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.229999999999997 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.099999999999994 111.151 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.299999999999997 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.869 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 62.32 110.873 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 30' ' ' PHE . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.100000000000001 110.868 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.854 0.359 . . . . 53.509999999999998 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 65.420000000000002 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.239999999999995 110.919 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 61.219999999999999 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 55.229999999999997 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 63.509999999999998 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 63.219999999999999 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.62 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.219999999999999 110.848 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 42.219999999999999 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.319999999999993 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.109999999999999 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 54.119999999999997 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.349999999999994 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 61.219999999999999 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 61.439999999999998 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.099999999999994 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 64.439999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 65.120000000000005 111.063 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 63.310000000000002 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 52.340000000000003 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 62.420000000000002 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.825 0.345 . . . . 62.310000000000002 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.409999999999997 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.219999999999999 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 111.153 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CE1' HD11 ' A' ' 33' ' ' ILE . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 110.877 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.010000000000005 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.140000000000001 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 54.340000000000003 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.239999999999995 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.91 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 42.0 112.471 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 62.240000000000002 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.030000000000001 111.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.893 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.796 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.882 0.372 . . . . 70.400000000000006 111.118 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.101 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.853 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 73.019999999999996 110.908 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.450000000000003 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 111.125 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 111.138 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.009999999999998 110.864 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 47' ' ' VAL . 10.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.828 0.346 . . . . 75.109999999999999 110.941 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 60.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.653 ' HA ' HG13 ' A' ' 6' ' ' VAL . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.892 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.439999999999998 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 63.549999999999997 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 41' ' ' LEU . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.319999999999993 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.420000000000002 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 64.329999999999998 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.540000000000006 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.150000000000006 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 50.310000000000002 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.109999999999999 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 72.239999999999995 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.510000000000005 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.128 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.913 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 65.340000000000003 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 74.129999999999995 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 64.439999999999998 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 62.109999999999999 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.854 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.84 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 50.329999999999998 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 61.329999999999998 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.67 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.109999999999999 112.493 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 71.120000000000005 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.855 HD12 HG11 ' A' ' 28' ' ' VAL . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.319999999999993 111.113 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.879 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.891 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 72.530000000000001 111.098 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' A' ' 62' ' ' ALA . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.120000000000005 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.731 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 64.040000000000006 110.846 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 111.092 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 30' ' ' PHE . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.093 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.91 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 47' ' ' VAL . 25.6 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.801 0.334 . . . . 74.329999999999998 110.91 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.868 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 50.240000000000002 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 62.240000000000002 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.439999999999998 110.861 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.340000000000003 111.152 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.646 ' O ' HG22 ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' A' ' 26' ' ' VAL . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.530000000000001 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 72.430000000000007 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.340000000000003 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.400000000000006 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.879 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.009999999999998 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 45.100000000000001 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 73.340000000000003 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.319999999999993 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.106 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 53.329999999999998 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 43.43 111.123 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.859 0.362 . . . . 71.530000000000001 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.510000000000005 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.200000000000003 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.121 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.763 ' CE1' HD13 ' A' ' 41' ' ' LEU . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.876 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 55.009999999999998 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.019999999999996 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.349999999999994 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 33.030000000000001 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 65.140000000000001 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 54.43 112.485 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 72.439999999999998 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.340000000000003 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.935 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 73.129999999999995 111.151 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 65.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 111.15 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.299999999999997 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.519999999999996 110.853 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 54.219999999999999 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 40.149999999999999 111.096 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 111.119 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.862 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.763 HD13 ' CE1' ' A' ' 9' ' ' PHE . 6.2 mp . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.817 0.341 . . . . 73.109999999999999 110.917 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 6' ' ' VAL . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 70.400000000000006 110.898 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.329999999999998 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 55.409999999999997 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG11 HD23 ' A' ' 41' ' ' LEU . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.12 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.439999999999998 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 26' ' ' VAL . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 62.25 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 64.450000000000003 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.911 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 43.43 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 72.019999999999996 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.030000000000001 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.519999999999996 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 71.400000000000006 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 71.400000000000006 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 55.439999999999998 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.911 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.310000000000002 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 60.520000000000003 111.114 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 70.129999999999995 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.768 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.019999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.884 0.373 . . . . 73.25 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.907 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.540000000000006 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 64.319999999999993 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.128 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 53.439999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.340000000000003 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 31.510000000000002 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 64.010000000000005 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.149999999999999 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' CD1' ' A' ' 49' ' ' PHE . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.139 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.627 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.911 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.120000000000005 110.926 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.68 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.872 0.368 . . . . 74.129999999999995 111.157 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 70.019999999999996 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 64.200000000000003 111.141 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 63.149999999999999 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HA ' HD12 ' A' ' 33' ' ' ILE . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.893 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.144 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 54.25 111.08 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.25 110.88 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 6' ' ' VAL . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 110.848 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 71.019999999999996 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.200000000000003 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.437 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 60.119999999999997 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.019999999999996 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.9 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.439999999999998 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 64.409999999999997 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.120000000000005 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 51.439999999999998 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 71.540000000000006 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 72.209999999999994 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 42.140000000000001 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.400000000000006 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.9 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 63.409999999999997 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.868 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.340000000000003 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 50.020000000000003 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.848 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.437 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.866 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 72.420000000000002 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 73.540000000000006 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 HD23 ' A' ' 41' ' ' LEU . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.229999999999997 111.105 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.88 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 33' ' ' ILE . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.826 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 54.219999999999999 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 44.020000000000003 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.129999999999995 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 44.140000000000001 112.466 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.510000000000005 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 111.161 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 63.539999999999999 110.912 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.941 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.846 0.355 . . . . 73.349999999999994 111.103 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.111 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.881 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.873 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 30' ' ' PHE . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 40.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.703 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.06 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 61.25 111.121 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.929 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD23 HG21 ' A' ' 6' ' ' VAL . 14.8 tp . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.805 0.336 . . . . 62.210000000000001 110.954 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HA ' HG13 ' A' ' 6' ' ' VAL . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.9 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 44.030000000000001 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.329999999999998 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.25 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 41' ' ' LEU . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 64.329999999999998 111.133 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 26' ' ' VAL . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 64.299999999999997 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 71.319999999999993 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 63.520000000000003 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 54.130000000000003 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 61.409999999999997 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 51' ' ' VAL . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 63.409999999999997 112.367 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 63.210000000000001 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 111.067 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 74.140000000000001 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 61.399999999999999 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 63.420000000000002 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 51.43 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.209999999999994 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 33' ' ' ILE . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.150000000000006 110.841 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.519999999999996 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 64.409999999999997 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 61.140000000000001 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.439999999999998 112.544 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 111.134 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 110.853 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.871 0.367 . . . . 74.129999999999995 111.177 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.450000000000003 111.131 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.887 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 55.299999999999997 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.869 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.811 0.338 . . . . 65.340000000000003 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 6' ' ' VAL . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.89 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 44.409999999999997 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.510000000000005 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.230000000000004 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.009999999999998 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' A' ' 26' ' ' VAL . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.539999999999999 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.030000000000001 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 54.210000000000001 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.430000000000007 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 44.399999999999999 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.219999999999999 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 54.420000000000002 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.140000000000001 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.450000000000003 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.43 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 64.420000000000002 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 63.350000000000001 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 61.119999999999997 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 63.329999999999998 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.420000000000002 111.135 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 33' ' ' ILE . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 53.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 54.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.340000000000003 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.310000000000002 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.340000000000003 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 26' ' ' VAL . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.106 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.643 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.916 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.691 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.864 0.364 . . . . 74.319999999999993 111.152 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 111.158 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.807 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.81 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 61.340000000000003 111.118 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.349999999999994 111.11 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.904 179.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.879 0.371 . . . . 62.530000000000001 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.129999999999995 110.843 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.149999999999999 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.439999999999998 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 51.32 110.928 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 54.549999999999997 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.329999999999998 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.129999999999995 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.210000000000001 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 62.130000000000003 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 43.32 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.150000000000006 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.099999999999994 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.94 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.815 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.082 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.815 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 62.329999999999998 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.536 ' O ' HD13 ' A' ' 68' ' ' ILE . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 64.420000000000002 110.873 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 67' ' ' ARG . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.539999999999999 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.857 0.361 . . . . 60.520000000000003 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 22.219999999999999 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.049999999999997 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 111.104 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.669 ' CE2' HD23 ' A' ' 41' ' ' LEU . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.420000000000002 110.885 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.299999999999997 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 55.43 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.200000000000003 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.239999999999995 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.329999999999998 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' HB ' HG12 ' A' ' 26' ' ' VAL . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 53.399999999999999 111.12 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.129999999999995 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 110.867 -179.885 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 41.100000000000001 111.121 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 33' ' ' ILE . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 110.841 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.131 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 60.119999999999997 111.13 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.099999999999994 110.897 179.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.669 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.1 mm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.838 0.351 . . . . 64.150000000000006 110.949 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 6' ' ' VAL . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.210000000000001 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.400000000000006 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 41' ' ' LEU . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.183 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HG11 ' A' ' 26' ' ' VAL . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 62.520000000000003 110.84 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.019999999999996 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.942 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' H ' ' H ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 51.310000000000002 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.109999999999999 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 43.549999999999997 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 50.009999999999998 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 61.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 43.310000000000002 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.942 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.103 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 53.210000000000001 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.299999999999997 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.099999999999994 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 63.43 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 70.239999999999995 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.219999999999999 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 111.111 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.530000000000001 110.904 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 65.450000000000003 110.816 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.420000000000002 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.209999999999994 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 35.009999999999998 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 55.200000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' HG12 ' A' ' 26' ' ' VAL . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.510000000000005 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.634 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.906 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.915 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 64.420000000000002 111.149 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.209999999999994 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 111.156 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.868 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 61.329999999999998 110.861 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 62.119999999999997 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 30' ' ' PHE . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.148 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 53.310000000000002 110.891 179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.854 0.359 . . . . 75.219999999999999 110.859 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.615 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.210000000000001 110.882 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.439999999999998 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.540000000000006 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 64.400000000000006 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD2' HG11 ' A' ' 26' ' ' VAL . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.853 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.240000000000002 110.866 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 63.409999999999997 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 41.399999999999999 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.140000000000001 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 71.510000000000005 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 54.329999999999998 111.075 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 64.099999999999994 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.842 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.414 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 64.340000000000003 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.030000000000001 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 71.010000000000005 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 43' ' ' GLU . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 61.329999999999998 111.142 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.907 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 41' ' ' LEU . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.120000000000005 110.885 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 55.149999999999999 111.099 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 52.539999999999999 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.109999999999999 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.109999999999999 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 31.399999999999999 112.482 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 49' ' ' PHE . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.624 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.885 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.944 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.893 0.377 . . . . 44.119999999999997 111.115 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.136 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.329999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.88 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.079 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 30' ' ' PHE . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.120000000000005 111.13 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.78 0.324 . . . . 62.149999999999999 110.936 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.918 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.530000000000001 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 63.25 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 18' ' ' ILE . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.917 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.319999999999993 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 44.149999999999999 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 55.530000000000001 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 41.25 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.239999999999995 110.905 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.049999999999997 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.439999999999998 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 71.329999999999998 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.450000000000003 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.540000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 111.122 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.439999999999998 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.767 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 61.310000000000002 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.841 0.353 . . . . 72.349999999999994 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.120000000000005 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 72.349999999999994 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 63.43 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.138 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.540000000000006 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.68 ' CD1' HD23 ' A' ' 41' ' ' LEU . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 110.878 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 50.119999999999997 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.310000000000002 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 62.119999999999997 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.329999999999998 112.516 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 53.210000000000001 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 45.100000000000001 111.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 72.109999999999999 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.89 -179.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.868 0.366 . . . . 73.439999999999998 111.123 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HB3' HG22 ' A' ' 31' ' ' THR . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.88 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 110.889 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 29' ' ' HIS . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 53.130000000000003 111.149 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 52.119999999999997 111.095 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 111.128 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.858 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.68 HD23 ' CD1' ' A' ' 9' ' ' PHE . 2.8 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.844 0.354 . . . . 73.239999999999995 110.952 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 35.329999999999998 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 41' ' ' LEU . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.13 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 53.25 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 26' ' ' VAL . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.439999999999998 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.922 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 71.5 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 65.209999999999994 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 44.299999999999997 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 53.399999999999999 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.230000000000004 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 73.010000000000005 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.922 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 53.039999999999999 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.140000000000001 111.079 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.833 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.099999999999994 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' C ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.866 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 111.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.877 0.37 . . . . 74.340000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.120000000000005 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.019999999999996 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.652 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 111.103 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.872 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 41' ' ' LEU . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.885 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 62.039999999999999 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.540000000000006 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 54.539999999999999 110.866 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.030000000000001 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.040000000000006 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 111.066 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.627 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.010000000000005 110.911 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 61.530000000000001 110.959 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 74.329999999999998 111.107 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.049999999999997 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 111.096 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.853 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.864 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.049999999999997 110.866 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.092 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 30' ' ' PHE . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 111.15 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 54.409999999999997 110.876 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CE1' ' A' ' 9' ' ' PHE . 2.6 mm? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.866 0.365 . . . . 74.019999999999996 110.938 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 42.240000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.912 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.409999999999997 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.340000000000003 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.329999999999998 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.91 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 72.319999999999993 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.149999999999999 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.299999999999997 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.349999999999994 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 53.149999999999999 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.030000000000001 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.530000000000001 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.349999999999994 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.409999999999997 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.91 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.782 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.539999999999999 111.075 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.200000000000003 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.120000000000005 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.383 . . . . 74.420000000000002 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.120000000000005 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 111.143 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 44.539999999999999 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.430000000000007 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 33' ' ' ILE . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.219999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.130000000000003 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.209999999999994 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.340000000000003 110.945 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.219999999999999 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.420000000000002 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.459 ' HB ' HG12 ' A' ' 26' ' ' VAL . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.127 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 61.119999999999997 110.934 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 110.878 -179.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 HG12 ' A' ' 51' ' ' VAL . 2.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.845 0.355 . . . . 53.509999999999998 111.118 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 64.299999999999997 111.14 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 22.1 m-70 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.867 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.866 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 73.030000000000001 111.099 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.128 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.884 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.229 0.021 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 45.140000000000001 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.635 ' HA ' HG13 ' A' ' 6' ' ' VAL . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.879 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 44.210000000000001 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' O ' HG22 ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 26' ' ' VAL . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 70.430000000000007 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.129999999999995 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 73.349999999999994 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 73.420000000000002 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.299999999999997 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 70.129999999999995 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.329999999999998 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.430000000000007 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 71.299999999999997 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.817 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.030000000000001 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.85 0.357 . . . . 74.209999999999994 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.100000000000001 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 72.209999999999994 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.430000000000007 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.340000000000003 110.844 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.310000000000002 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 71.209999999999994 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.409999999999997 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.140000000000001 112.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.150000000000006 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.905 HD12 HG11 ' A' ' 28' ' ' VAL . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.450000000000003 111.162 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.92 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.933 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.8 0.333 . . . . 63.409999999999997 111.17 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.905 HG11 HD12 ' A' ' 18' ' ' ILE . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.126 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 111.146 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 70.420000000000002 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.0 mm? . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.827 0.346 . . . . 71.409999999999997 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.863 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.450000000000003 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.530000000000001 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.530000000000001 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 63.149999999999999 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.450000000000003 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 HG21 ' A' ' 26' ' ' VAL . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.349999999999994 110.908 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 43.329999999999998 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.119999999999997 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 64.319999999999993 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.530000000000001 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.349999999999994 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.340000000000003 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 53.130000000000003 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.823 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 111.095 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 65.140000000000001 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' C ' HG12 ' A' ' 68' ' ' ILE . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.510000000000005 110.811 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.405 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 64.450000000000003 110.866 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.210000000000001 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 111.107 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.87 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' HD11 ' A' ' 33' ' ' ILE . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.019999999999996 110.854 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 63.5 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.239999999999995 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.409999999999997 112.473 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 71.010000000000005 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.340000000000003 111.138 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.905 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 110.899 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.731 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 63.119999999999997 111.14 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 111.133 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB3' HG22 ' A' ' 31' ' ' THR . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.844 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.329999999999998 110.891 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' HIS . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.519999999999996 111.158 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 111.094 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 30' ' ' PHE . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.009999999999998 111.057 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 64.109999999999999 110.909 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.802 0.334 . . . . 65.530000000000001 110.936 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 62.509999999999998 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HA ' HG13 ' A' ' 6' ' ' VAL . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.049999999999997 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 35.219999999999999 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 51.409999999999997 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.938 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.349999999999994 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.329999999999998 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 24.129999999999999 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 44.420000000000002 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.209999999999994 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 61.140000000000001 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.938 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 63.340000000000003 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.129999999999995 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 61.200000000000003 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 73.010000000000005 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.450000000000003 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.616 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 111.127 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.100000000000001 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.030000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HE2' HD11 ' A' ' 33' ' ' ILE . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 51.119999999999997 110.881 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 50.520000000000003 111.13 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 70.25 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.510000000000005 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.030000000000001 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 64.329999999999998 111.173 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 110.923 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.874 0.368 . . . . 74.219999999999999 111.138 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 60.420000000000002 111.143 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 55.200000000000003 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 70.439999999999998 110.865 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.450000000000003 111.117 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.420000000000002 111.145 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.430000000000007 110.853 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.23 0.033 0 CA-C-O 120.826 0.346 . . . . 74.519999999999996 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 61.009999999999998 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.616 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 110.884 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 31.34 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.109999999999999 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.5 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.010000000000005 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.099999999999994 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 70.150000000000006 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 63.049999999999997 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.540000000000006 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.349999999999994 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.319999999999993 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.219999999999999 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.349999999999994 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.933 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.230000000000004 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 51.509999999999998 111.11 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.310000000000002 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.795 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 64.299999999999997 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.837 0.351 . . . . 70.129999999999995 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 63.509999999999998 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.230000000000004 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.129999999999995 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 51.240000000000002 111.091 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HE1' HD11 ' A' ' 33' ' ' ILE . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.911 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.150000000000006 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.135 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.140000000000001 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.510000000000005 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' VAL . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 110.84 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 55.450000000000003 111.105 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 7' ' ' LYS . 1.3 mm-40 -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.888 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.929 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.704 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.822 0.344 . . . . 60.219999999999999 111.112 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.149999999999999 111.157 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.140000000000001 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 42.119999999999997 111.089 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 30' ' ' PHE . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 111.133 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.904 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 HG11 ' A' ' 47' ' ' VAL . 38.2 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 74.510000000000005 110.914 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 45.299999999999997 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 53.119999999999997 110.92 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 54.100000000000001 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.619 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.099999999999994 111.149 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 26' ' ' VAL . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 110.919 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 44.530000000000001 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.430000000000007 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.140000000000001 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 74.299999999999997 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.530000000000001 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 54.340000000000003 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 60.240000000000002 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 73.040000000000006 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.219999999999999 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.210000000000001 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.084 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 73.299999999999997 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.420000000000002 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.530000000000001 111.13 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 55.200000000000003 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -118.05 148.45 42.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 110.886 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.1 mtmm -119.79 133.37 55.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.450000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 171.1 40.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 55.130000000000003 112.527 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.11 156.59 31.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 111.147 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.0 p -100.2 130.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 111.113 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -34.93 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.530000000000001 110.907 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -170.96 142.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.514 ' HE2' HD11 ' A' ' 33' ' ' ILE . 41.7 t80 -138.81 106.88 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.92 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.82 101.86 11.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 75.019999999999996 110.877 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.19 -23.23 51.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 61.32 111.115 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.76 -25.6 61.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 71.349999999999994 110.889 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -105.54 -40.33 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 55.439999999999998 110.923 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.33 42.58 2.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 35.43 112.525 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.4 p90 -148.65 166.76 27.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 75.430000000000007 110.91 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.7 175.19 45.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 54.119999999999997 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -137.07 134.76 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 61.32 110.901 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 mt -120.03 147.93 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.132 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -124.38 123.86 41.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 110.946 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 6.3 pt20 -100.23 -172.31 2.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 110.913 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -60.17 -24.99 65.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 53.140000000000001 110.838 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 96.1 mt-10 -50.89 -75.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 73.030000000000001 110.887 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.81 -66.39 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 73.129999999999995 112.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 167.14 25.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 51.43 112.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -86.46 -175.6 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.846 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -136.26 152.07 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 70.519999999999996 111.103 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -86.02 115.28 23.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 75.310000000000002 110.894 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.93 145.61 31.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.135 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.3 m-70 -145.74 162.7 36.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.874 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.2 p90 -58.71 -19.63 41.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.420000000000002 110.856 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.9 p -86.43 6.14 31.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 111.128 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.78 -32.77 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 30' ' ' PHE . 20.4 mt -51.24 129.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 111.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -109.35 89.88 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 71.25 110.909 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.04 172.22 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 52.140000000000001 111.098 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.83 76.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.856 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.88 -118.54 3.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -65.54 112.29 3.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.37 . . . . 71.150000000000006 110.885 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HB2' HG21 ' A' ' 33' ' ' ILE . 15.5 ptt180 -99.96 49.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 65.209999999999994 110.858 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.8 m -118.47 135.21 54.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.122 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? -109.09 179.07 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 110.911 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -132.59 131.54 41.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 60.229999999999997 110.915 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' HG13 ' A' ' 6' ' ' VAL . 67.0 tt0 -53.18 131.89 37.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 75.439999999999998 110.893 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.48 65.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 65.140000000000001 112.467 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.13 159.98 18.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 73.219999999999999 110.894 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.8 m-70 -92.57 140.6 29.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.823 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.3 m -154.52 142.07 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' HG22 ' A' ' 65' ' ' VAL . 27.6 tt0 -84.88 163.89 18.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.230000000000004 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.4 p90 -167.1 129.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 62.439999999999998 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 68.8 mt-10 -98.27 100.7 12.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.891 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.928 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 32.1 m -64.24 127.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.101 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 5.6 mm-40 -119.38 160.14 42.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 73.109999999999999 110.877 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -89.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.351 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.69 61.72 4.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 54.039999999999999 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.85 -41.28 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.120000000000005 110.897 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.92 150.22 17.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.726 -0.75 . . . . 74.200000000000003 112.468 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.04 -58.16 8.09 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.129999999999995 112.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.27 -11.86 60.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.331 . . . . 73.439999999999998 110.902 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.87 -80.38 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.759 . . . . 73.129999999999995 112.474 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 111.49 2.81 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.646 2.231 . . . . 75.140000000000001 112.358 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.928 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.8 tt0 -115.89 162.68 16.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.43 58.68 5.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 111.048 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -44.0 -39.97 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 110.919 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.09 95.12 4.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 71.219999999999999 110.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -101.01 142.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 111.155 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -132.44 151.64 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 62.210000000000001 110.869 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.12 133.52 34.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 70.019999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.436 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 53.030000000000001 111.104 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.89 0.376 . . . . 44.439999999999998 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -130.34 145.13 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 72.109999999999999 110.914 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.7 mttm -113.77 137.39 51.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.340000000000003 110.906 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.58 172.13 43.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.430000000000007 112.489 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -76.27 156.65 33.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 52.409999999999997 111.145 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.617 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.6 p -96.52 131.41 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.159 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD3' ' HG3' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -80.44 -35.03 35.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.92 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -174.54 142.65 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.943 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' HE2' HD11 ' A' ' 33' ' ' ILE . 38.2 t80 -137.72 118.87 14.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.888 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -99.64 109.6 22.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 63.5 110.882 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.33 -25.11 46.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.091 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.06 -42.08 99.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 51.5 110.9 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -92.91 -39.97 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 64.420000000000002 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 40.57 2.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 65.549999999999997 112.517 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.2 170.2 17.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 72.030000000000001 110.915 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.69 178.38 47.97 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 45.549999999999997 112.489 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -136.33 140.35 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.804 0.335 . . . . 75.420000000000002 110.814 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.6 mt -119.77 146.55 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 111.151 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HG3' ' HD3' ' A' ' 7' ' ' LYS . 25.7 mm-40 -113.53 116.92 30.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 63.100000000000001 110.917 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -99.23 -174.43 2.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -67.45 -24.66 65.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 44.409999999999997 110.926 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.99 -70.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.209999999999994 110.888 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 -68.46 0.21 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.745 . . . . 64.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 165.74 29.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 63.240000000000002 112.362 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -80.32 -175.3 5.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.849 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -138.4 151.31 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 70.109999999999999 111.188 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -84.43 115.41 22.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.834 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -124.36 144.09 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 63.310000000000002 111.147 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.72 160.31 40.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.842 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.81 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.0 p90 -59.07 -19.51 44.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.883 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.21 6.67 39.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 55.219999999999999 111.162 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -132.57 4.38 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.129999999999995 111.074 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.0 mt -90.55 125.66 43.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.24 86.43 2.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.899 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 174.75 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 64.200000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.64 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 72.030000000000001 110.857 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.52 -147.96 17.0 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.689 -0.767 . . . . 54.229999999999997 112.467 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -68.05 111.85 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 64.310000000000002 110.895 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -64.55 101.76 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.25 110.838 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.47 ' C ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -152.5 135.98 16.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.152 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 40' ' ' THR . 11.0 mp -118.48 164.44 15.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 110.898 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -126.1 127.29 45.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.879 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.2 tt0 -51.25 125.24 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.852 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.39 -13.44 51.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 60.340000000000003 112.492 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.31 159.01 18.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 73.530000000000001 110.902 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -92.65 140.01 29.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.856 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.8 m -155.15 142.62 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 63.329999999999998 111.118 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 65' ' ' VAL . 73.3 tt0 -87.91 162.72 16.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.32 110.874 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 26' ' ' VAL . 50.9 p90 -165.55 129.43 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 110.929 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.4 mt-10 -91.57 101.08 13.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.864 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 8.9 m -49.25 102.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 70.129999999999995 111.142 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.57 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 tt0 -74.16 144.3 81.62 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.641 0.734 . . . . 72.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.72 -93.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 72.019999999999996 112.323 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.58 57.12 3.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 74.120000000000005 112.458 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -39.91 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 60.310000000000002 110.833 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.98 140.87 23.62 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.9 -51.72 12.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.685 -0.769 . . . . 62.149999999999999 112.492 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -87.94 -3.01 58.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.120000000000005 110.933 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.1 -80.38 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.771 -0.728 . . . . 61.109999999999999 112.508 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 117.4 5.06 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.703 2.269 . . . . 64.340000000000003 112.336 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.811 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.2 tt0 -116.41 -177.97 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.737 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -99.26 51.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 111.095 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -38.48 -42.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 60.109999999999999 110.901 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -134.54 97.14 3.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 54.549999999999997 110.921 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.737 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -99.1 142.69 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 62.25 111.131 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -132.96 153.73 51.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.119999999999997 110.849 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.16 131.61 37.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.846 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.140000000000001 111.164 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 71.420000000000002 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -126.98 131.86 50.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.319999999999993 110.897 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -115.68 137.59 51.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.888 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 172.14 45.11 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.745 -0.741 . . . . 64.349999999999994 112.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -72.06 157.75 37.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.829 0.347 . . . . 74.25 111.159 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.2 p -96.84 129.23 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 63.200000000000003 111.126 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.88 -40.24 63.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.867 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -173.44 147.04 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.907 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.61 ' CE1' HD11 ' A' ' 33' ' ' ILE . 47.0 t80 -132.95 101.01 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 110.878 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -81.05 99.55 8.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.099999999999994 110.879 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.22 -22.85 59.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.13 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -61.48 -27.58 68.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 61.509999999999998 110.89 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -114.82 -36.81 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.94 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 43.4 2.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 70.239999999999995 112.48 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -145.98 169.37 18.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 65.540000000000006 110.934 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.91 178.78 46.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 45.240000000000002 112.505 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -136.19 140.43 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.342 . . . . 74.230000000000004 110.907 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.22 144.44 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 111.095 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -115.99 121.86 43.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 70.230000000000004 110.926 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.0 -167.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 71.0 110.913 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.68 -27.15 68.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.872 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 3.2 mm-40 -48.87 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.463 . . . . 74.120000000000005 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.54 -66.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.775 -0.726 . . . . 60.340000000000003 112.504 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 165.81 29.66 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.639 2.226 . . . . 74.340000000000003 112.371 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -82.73 171.65 13.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 74.530000000000001 110.867 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.797 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -127.26 151.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 54.340000000000003 111.166 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -85.47 115.9 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.229999999999997 110.843 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.11 144.72 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.099999999999994 111.151 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.73 159.54 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.299999999999997 110.827 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.869 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.9 p90 -60.01 -19.04 50.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 62.32 110.873 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -85.14 4.68 33.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 111.144 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.84 -32.73 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.43 111.168 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 30' ' ' PHE . 17.9 mt -51.41 130.44 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.5 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -110.49 87.68 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 62.100000000000001 110.868 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.48 172.31 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 111.061 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.21 75.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.907 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.9 140.01 5.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.73 -0.747 . . . . 64.049999999999997 112.478 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -54.03 110.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 52.409999999999997 110.908 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -152.67 179.3 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 53.399999999999999 110.877 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -132.48 -178.55 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 63.350000000000001 111.166 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 41' ' ' LEU . 3.3 mm? -110.14 176.83 4.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 53.509999999999998 110.896 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -130.38 131.47 45.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 65.420000000000002 110.838 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 tt0 -54.22 128.21 30.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.239999999999995 110.919 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.71 56.95 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 61.219999999999999 112.464 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -84.65 157.95 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 55.229999999999997 110.906 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -90.66 140.4 29.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 63.509999999999998 110.833 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.66 142.0 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 63.219999999999999 111.099 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.62 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.2 tt0 -86.69 161.79 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.878 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.9 p90 -164.16 130.18 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.37 100.44 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 70.219999999999999 110.848 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.927 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -64.74 127.7 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 42.219999999999999 111.143 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -119.89 159.84 45.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.887 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -89.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.726 2.284 . . . . 74.319999999999993 112.375 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.68 60.9 4.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -41.45 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 73.109999999999999 110.894 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.83 149.89 17.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.763 -0.732 . . . . 54.119999999999997 112.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.96 -58.44 7.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.754 -0.736 . . . . 75.349999999999994 112.448 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -67.96 -12.11 60.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 61.219999999999999 110.904 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.75 -80.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.742 -0.742 . . . . 61.439999999999998 112.464 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 112.69 3.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.729 2.286 . . . . 73.099999999999994 112.345 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.927 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.8 tt0 -116.84 162.55 17.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 64.439999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.811 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.37 59.43 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 65.120000000000005 111.063 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -43.54 -43.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 63.310000000000002 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -127.63 99.04 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.935 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.27 144.06 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.111 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -132.65 152.68 51.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 52.340000000000003 110.873 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -91.18 131.97 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.884 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 62.420000000000002 111.127 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ptt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.862 0.363 . . . . 73.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -130.47 155.4 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 62.310000000000002 110.887 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -114.66 136.15 53.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.888 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.39 170.46 40.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.409999999999997 112.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 p -76.55 158.7 30.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 74.219999999999999 111.141 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG13 ' HA ' ' A' ' 43' ' ' GLU . 8.2 p -101.42 134.15 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 111.153 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -36.85 29.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.88 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -171.6 144.56 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.944 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CE1' HD11 ' A' ' 33' ' ' ILE . 63.0 t80 -139.61 108.74 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.310000000000002 110.877 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.19 117.51 27.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 71.010000000000005 110.915 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.4 -23.98 27.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 61.140000000000001 111.103 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.12 -40.3 84.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -100.59 -38.84 8.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 54.340000000000003 110.879 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.85 45.71 1.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 75.239999999999995 112.467 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.7 p90 -145.84 171.42 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.91 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -178.19 179.58 48.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 42.0 112.471 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -137.22 141.3 42.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 62.240000000000002 110.847 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.6 mt -120.84 151.11 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.030000000000001 111.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -123.15 118.41 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.896 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 -166.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.893 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -69.12 -27.65 65.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -48.13 -71.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 110.913 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -66.5 0.26 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.689 -0.767 . . . . 64.439999999999998 112.431 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 164.12 35.75 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.721 2.281 . . . . 51.520000000000003 112.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.94 -169.85 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 75.329999999999998 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.796 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -146.41 151.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.118 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.19 114.91 22.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 70.25 110.917 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.44 144.23 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.101 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 m-70 -145.5 162.59 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.853 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -59.12 -19.99 49.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 73.019999999999996 110.908 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -88.2 2.71 51.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 70.450000000000003 111.136 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -125.8 -3.69 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 111.125 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -82.32 127.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 111.138 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.35 93.39 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 55.009999999999998 110.864 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . . . -137.74 179.08 6.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 70.409999999999997 111.136 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.53 77.9 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 64.219999999999999 110.858 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.12 -117.82 3.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -70.99 110.04 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 74.030000000000001 110.885 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HG3' ' HB3' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -88.78 58.11 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.895 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -121.45 138.5 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 73.219999999999999 111.171 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 47' ' ' VAL . 10.1 mt -109.26 169.56 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.109999999999999 110.941 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -129.07 131.42 47.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 60.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.653 ' HA ' HG13 ' A' ' 6' ' ' VAL . 63.7 tt0 -51.7 135.5 28.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.892 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.7 -12.81 67.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 70.439999999999998 112.529 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -87.93 159.92 18.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.918 0.39 . . . . 63.549999999999997 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.2 m-70 -94.82 139.5 31.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.0 110.859 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.499 HG21 HD13 ' A' ' 41' ' ' LEU . 33.0 m -154.72 142.94 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.16 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 65' ' ' VAL . 53.1 tt0 -86.03 163.25 18.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.319999999999993 110.936 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.6 p90 -166.59 129.62 1.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.884 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.1 tt0 -99.98 101.3 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 65.420000000000002 110.859 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.2 124.32 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 65.310000000000002 111.092 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -112.57 159.57 33.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.601 0.715 . . . . 64.329999999999998 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -90.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 74.329999999999998 112.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.96 62.56 4.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 74.540000000000006 112.482 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -132.32 -41.2 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.373 . . . . 74.150000000000006 110.854 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.53 149.51 16.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 50.310000000000002 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -57.55 8.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.109999999999999 112.523 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -70.5 -9.91 57.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 72.239999999999995 110.874 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.61 -80.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 64.510000000000005 112.516 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 111.7 2.88 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.5 tt0 -116.96 162.89 17.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.944 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.51 56.83 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.128 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -42.39 -41.43 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.913 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -128.31 95.52 4.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 110.912 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -101.19 143.19 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.138 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -132.96 151.16 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 110.876 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -89.73 133.35 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 110.869 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.438 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.101 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.867 0.365 . . . . 53.530000000000001 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -118.13 145.61 44.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.893 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.0 mttt -124.34 128.77 49.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 74.129999999999995 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.02 173.11 40.85 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.758 -0.734 . . . . 64.439999999999998 112.475 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -73.96 157.29 36.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.839 0.352 . . . . 62.109999999999999 111.134 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.9 p -95.88 129.09 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.13 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.42 -36.74 63.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.854 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -175.51 147.42 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.442 ' HE2' ' HG1' ' A' ' 40' ' ' THR . 7.0 t80 -121.56 99.03 6.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 73.519999999999996 110.84 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -76.18 86.01 3.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 50.329999999999998 110.875 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.27 62.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.097 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -59.68 -32.98 71.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -108.9 -30.52 8.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.894 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.0 26.79 7.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.48 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -126.31 178.84 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.927 0.394 . . . . 61.329999999999998 110.942 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.67 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -170.96 174.43 44.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 71.109999999999999 112.493 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -138.35 126.77 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 71.120000000000005 110.918 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.855 HD12 HG11 ' A' ' 28' ' ' VAL . 17.4 mt -111.79 147.34 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.319999999999993 111.113 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -120.46 124.18 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.879 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -111.79 175.31 5.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.41 -23.21 14.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 71.109999999999999 110.905 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.55 -72.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.832 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.9 -69.24 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.515 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 166.12 28.75 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 2.251 . . . . 70.519999999999996 112.329 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.42 -173.26 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 72.129999999999995 110.881 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -143.48 151.75 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 111.098 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.4 115.76 27.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.936 HG12 ' HB2' ' A' ' 62' ' ' ALA . 2.4 m -124.61 148.18 29.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.49 . . . . 72.120000000000005 111.136 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -135.44 160.72 37.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 110.86 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.731 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -60.57 -22.11 63.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 64.040000000000006 110.846 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -84.78 -19.6 32.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.161 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -90.15 -21.57 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.230000000000004 111.092 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 30' ' ' PHE . 4.7 mt -67.79 127.82 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.093 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.93 92.01 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.91 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.43 168.31 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.094 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -111.24 74.4 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.87 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.91 163.23 11.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 53.210000000000001 112.523 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -55.66 110.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 55.229999999999997 110.922 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -142.8 -173.79 3.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.898 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.442 ' HG1' ' HE2' ' A' ' 9' ' ' PHE . 13.5 t -162.96 174.62 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 70.219999999999999 111.165 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 47' ' ' VAL . 25.6 mt -108.99 159.84 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 74.329999999999998 110.91 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -129.87 130.6 45.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.881 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.3 tt0 -52.0 123.82 11.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.868 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.3 -16.77 41.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 50.240000000000002 112.509 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.43 157.25 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 62.240000000000002 110.918 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 6.4 m-70 -92.09 140.74 29.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.439999999999998 110.861 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -155.2 142.04 11.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.340000000000003 111.152 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.646 ' O ' HG22 ' A' ' 65' ' ' VAL . 68.6 tt0 -85.74 161.89 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.498 ' CD2' HG11 ' A' ' 26' ' ' VAL . 26.5 p90 -163.34 131.28 3.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.873 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.93 98.34 9.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.906 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.88 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.2 m -64.09 125.58 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 74.530000000000001 111.116 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.5 mm-40 -112.17 160.17 31.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.694 0.759 . . . . 72.430000000000007 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 64.340000000000003 112.374 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.37 61.9 4.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.400000000000006 112.525 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 17.2 tpt180 -131.4 -41.05 1.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.879 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -103.21 145.88 16.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.812 -0.708 . . . . 53.009999999999998 112.492 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -51.8 24.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 45.100000000000001 112.476 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -76.04 -12.82 60.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 73.340000000000003 110.893 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.26 -78.86 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 72.319999999999993 112.481 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 112.52 3.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.343 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.1 tp60 -115.39 151.47 34.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.858 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -81.1 57.62 3.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.106 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -41.6 -50.37 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.922 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -121.22 101.6 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.918 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.14 143.2 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 53.329999999999998 111.149 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -132.11 153.78 50.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.907 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -90.89 134.48 34.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 43.43 111.123 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.894 0.378 . . . . 73.540000000000006 110.884 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -111.75 129.45 56.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 71.530000000000001 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.3 mttp -109.42 133.01 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 110.921 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.55 171.38 42.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 74.510000000000005 112.488 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -75.59 158.46 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 72.200000000000003 111.088 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.1 p -101.54 135.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.121 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 -37.0 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.885 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -170.1 143.85 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.925 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' CE1' HD13 ' A' ' 41' ' ' LEU . 62.3 t80 -137.65 102.26 4.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.876 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -83.75 112.64 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.86 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.69 -23.85 31.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 55.009999999999998 111.087 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.15 -39.08 81.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.019999999999996 110.901 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -100.94 -37.9 8.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 71.349999999999994 110.901 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.04 44.86 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.716 -0.754 . . . . 33.030000000000001 112.498 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -146.05 169.98 17.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 65.140000000000001 110.918 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -175.64 176.6 47.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 54.43 112.485 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -136.64 138.17 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 72.439999999999998 110.87 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.7 mt -119.17 151.49 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 74.340000000000003 111.175 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -122.84 117.88 26.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.935 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.84 -168.24 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.935 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.03 -29.14 70.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 60.229999999999997 110.889 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -46.86 -72.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.899 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.48 -66.7 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 71.420000000000002 112.493 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 164.54 34.16 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 75.319999999999993 112.304 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -178.87 6.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -136.57 151.12 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 111.151 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -85.27 115.59 23.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 65.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.49 144.26 36.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.230000000000004 111.15 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -145.08 162.22 37.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 74.299999999999997 110.862 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -59.24 -19.88 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.519999999999996 110.853 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 m -86.5 1.72 50.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 54.219999999999999 111.129 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -119.42 -25.46 6.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 40.149999999999999 111.096 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 13.2 mt -58.69 128.69 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 111.119 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -105.51 90.76 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 74.019999999999996 110.862 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . . . -133.44 170.38 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 62.329999999999998 111.109 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.73 78.24 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 63.539999999999999 110.845 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.76 -117.58 3.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 60.100000000000001 112.489 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -82.26 110.87 17.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 72.099999999999994 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.559 ' HB2' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.54 122.98 46.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 110.919 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -160.0 134.9 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 111.134 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.763 HD13 ' CE1' ' A' ' 9' ' ' PHE . 6.2 mp -109.14 158.26 17.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.917 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.24 131.85 47.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.658 ' HA ' HG13 ' A' ' 6' ' ' VAL . 64.4 tt0 -52.22 134.59 33.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 70.400000000000006 110.898 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.0 -13.13 67.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.515 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -87.88 159.88 18.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 73.329999999999998 110.903 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -93.09 140.83 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 55.409999999999997 110.88 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG11 HD23 ' A' ' 41' ' ' LEU . 33.5 m -155.48 142.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.12 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.6 tt0 -86.89 162.81 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.439999999999998 110.877 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 26' ' ' VAL . 49.9 p90 -167.4 128.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 62.25 110.907 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 8.9 mt-10 -95.84 101.28 12.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 64.450000000000003 110.921 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.911 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.6 m -61.98 122.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 43.43 111.19 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -106.2 158.32 32.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 72.019999999999996 110.886 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.7 Cg_endo -69.77 -91.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 71.030000000000001 112.359 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.41 62.05 4.62 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 75.519999999999996 112.506 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tpt85 -133.21 -41.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 71.400000000000006 110.855 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.52 146.85 18.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.505 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.71 -54.94 12.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 71.400000000000006 112.511 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -76.19 -8.49 57.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.907 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.8 -79.48 0.35 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 61.32 112.515 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 112.34 3.06 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.689 2.259 . . . . 55.439999999999998 112.355 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.911 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -113.91 161.5 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 65.310000000000002 110.906 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.36 57.09 4.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 60.520000000000003 111.114 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 14.9 tppt? -42.21 -44.83 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.897 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 7.0 mmpt? -126.96 96.03 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 70.129999999999995 110.885 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.768 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.96 140.77 18.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.019999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -132.4 153.99 50.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.849 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -91.82 132.82 36.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.877 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 111.185 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.855 0.36 . . . . 73.430000000000007 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -118.76 149.7 41.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.882 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.9 mttp -124.7 128.99 49.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.907 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.57 173.58 40.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.722 . . . . 70.540000000000006 112.5 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 p -72.99 159.84 33.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.834 0.35 . . . . 64.319999999999993 111.119 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -102.51 131.57 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.128 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -38.68 59.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.904 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -173.79 145.95 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.931 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.59 99.39 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -86.25 106.5 17.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 53.439999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.04 -22.8 64.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 64.340000000000003 111.146 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.33 -34.73 78.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -103.15 -38.56 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.927 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.6 2.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.698 -0.763 . . . . 31.510000000000002 112.45 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.85 155.69 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 64.010000000000005 110.933 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.32 177.15 40.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.789 -0.72 . . . . 44.149999999999999 112.55 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -136.92 137.8 39.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 110.87 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG21 ' CD1' ' A' ' 49' ' ' PHE . 21.5 mt -120.81 146.97 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.139 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.627 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -124.29 128.33 48.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.911 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.48 -179.12 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 75.120000000000005 110.926 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -21.52 23.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.858 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -52.16 -73.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.71 -68.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 63.109999999999999 112.52 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 168.14 22.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.25 . . . . 53.130000000000003 112.369 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.0 172.88 8.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 52.32 110.898 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.68 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.83 150.75 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -88.55 114.91 25.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 70.019999999999996 110.903 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -121.92 152.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 64.200000000000003 111.141 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -150.25 159.34 44.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 63.149999999999999 110.872 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.663 ' HA ' HD12 ' A' ' 33' ' ' ILE . 7.1 p90 -58.29 -19.62 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.893 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -84.89 6.33 25.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.132 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.1 -39.45 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.144 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -51.74 127.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 54.25 111.08 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -112.84 85.8 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.25 110.88 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -112.47 177.72 4.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.530000000000001 111.092 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.4 74.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.832 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.65 -117.59 3.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 75.010000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -87.81 110.07 20.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 64.109999999999999 110.873 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 30.6 mtm180 -77.03 125.82 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.140000000000001 110.839 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -166.28 122.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 72.200000000000003 111.172 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 mt -108.87 -178.03 3.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 64.420000000000002 110.93 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -142.34 135.45 28.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.914 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 6' ' ' VAL . 28.6 tt0 -53.73 134.1 42.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 110.848 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.06 59.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 71.019999999999996 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -82.95 159.79 22.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.377 . . . . 74.200000000000003 110.907 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -91.83 140.28 29.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 110.875 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.437 ' HA ' HG13 ' A' ' 68' ' ' ILE . 33.4 m -155.02 141.91 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 60.119999999999997 111.093 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.63 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.7 tt0 -84.49 162.92 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 110.891 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 47.5 p90 -164.59 130.57 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 72.019999999999996 110.887 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -100.44 101.51 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 110.87 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.9 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.4 m -63.25 126.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.439999999999998 111.084 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -121.66 161.8 39.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 64.409999999999997 110.874 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -90.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.683 2.256 . . . . 71.120000000000005 112.307 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 61.89 3.53 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 51.439999999999998 112.51 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -131.27 -41.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.812 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.5 148.5 18.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 71.540000000000006 112.478 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -56.0 12.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.499 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -13.48 62.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 72.209999999999994 110.906 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.35 -79.67 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 42.140000000000001 112.451 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 112.92 3.2 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 74.400000000000006 112.315 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.9 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.3 tm0? -116.68 164.75 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 63.409999999999997 110.851 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.868 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.06 57.08 4.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 111.102 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.68 -38.34 2.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.230000000000004 110.895 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -131.59 97.01 4.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.908 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.44 139.06 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.340000000000003 111.152 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -132.05 151.76 51.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 50.020000000000003 110.837 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -86.1 136.01 33.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.409999999999997 110.848 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.437 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.5 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -110.99 128.89 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 110.872 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.0 mtmt -113.77 133.19 55.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.866 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 171.88 44.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 72.420000000000002 112.502 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -72.96 158.46 35.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 73.540000000000006 111.155 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG21 HD23 ' A' ' 41' ' ' LEU . 12.3 p -98.21 129.0 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 62.229999999999997 111.105 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -73.02 -38.84 66.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.88 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -174.69 147.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.219999999999999 110.935 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 33' ' ' ILE . 38.3 t80 -141.99 99.36 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.826 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -85.2 106.79 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 54.219999999999999 110.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.17 -26.09 64.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 111.124 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.87 -36.35 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.843 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -99.85 -36.3 9.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.109999999999999 110.888 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.87 37.89 5.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.682 -0.771 . . . . 44.020000000000003 112.513 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -144.23 171.69 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 74.129999999999995 110.931 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -176.63 178.55 47.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 44.140000000000001 112.466 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -135.24 141.31 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 75.510000000000005 110.887 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.5 mt -119.99 142.29 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 111.161 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -113.79 120.0 39.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 63.539999999999999 110.912 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 12.1 pt20 -106.25 -169.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.941 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.06 -26.11 66.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.530000000000001 110.842 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 13.6 mm-40 -49.77 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.898 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.64 -66.48 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 65.140000000000001 112.498 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 165.64 30.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.652 2.235 . . . . 64.329999999999998 112.336 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.77 178.0 8.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.530000000000001 110.891 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -133.83 151.07 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.103 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -84.71 116.32 23.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.902 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.51 144.09 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.111 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -144.52 159.53 42.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.340000000000003 110.867 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.881 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.3 p90 -60.78 -19.26 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.873 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 30' ' ' PHE . 75.3 p -84.52 4.12 33.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 40.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.703 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.0 -31.61 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.06 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.7 mt -51.09 127.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 61.25 111.121 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -105.79 92.09 4.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.929 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.3 171.94 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 55.219999999999999 111.125 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.03 74.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.200000000000003 110.867 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.87 138.05 5.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 72.530000000000001 112.468 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -52.54 124.83 14.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.899 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.34 129.19 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.86 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.5 t -81.01 174.65 11.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.010000000000005 111.13 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD23 HG21 ' A' ' 6' ' ' VAL . 14.8 tp -109.61 168.18 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 62.210000000000001 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -121.37 126.93 50.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.851 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HA ' HG13 ' A' ' 6' ' ' VAL . 75.4 tt0 -54.0 119.92 5.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.9 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.35 27.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 44.030000000000001 112.478 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -82.05 157.86 23.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.329999999999998 110.869 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -91.56 140.21 29.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.25 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 41' ' ' LEU . 34.3 m -155.9 143.68 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 64.329999999999998 111.133 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.2 tt0 -87.95 162.23 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.876 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 26' ' ' VAL . 42.4 p90 -162.99 132.37 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.872 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 1.5 mm-40 -96.69 101.22 12.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 2.3 p -62.25 123.03 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.156 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.73 155.16 49.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.636 0.731 . . . . 64.299999999999997 110.905 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.703 2.268 . . . . 71.319999999999993 112.382 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.25 62.41 4.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.515 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -131.91 -41.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 63.520000000000003 110.868 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.02 150.15 16.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.763 . . . . 54.130000000000003 112.496 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.64 -57.27 8.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 61.409999999999997 112.464 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -70.65 -10.83 60.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.91 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.86 -79.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.457 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 51' ' ' VAL . 53.8 Cg_endo -69.73 114.08 3.58 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 63.409999999999997 112.367 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.1 tt0 -119.59 169.5 10.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 63.210000000000001 110.891 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -96.99 62.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 111.067 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.82 -37.91 6.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 74.140000000000001 110.9 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 7.4 mmpt? -130.03 99.18 4.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.911 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -104.83 143.58 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -131.82 152.19 51.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.864 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -90.92 130.91 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 63.219999999999999 110.862 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 61.399999999999999 111.126 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 62.549999999999997 110.891 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -121.66 149.85 42.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 63.420000000000002 110.892 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 15.6 mtmm -123.47 135.53 54.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.95 172.09 44.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 51.43 112.501 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -73.8 158.25 34.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 64.209999999999994 111.179 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.1 p -97.57 128.77 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -36.39 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.873 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -175.38 145.85 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.885 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE1' HD11 ' A' ' 33' ' ' ILE . 51.0 t80 -138.12 106.13 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.150000000000006 110.841 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -85.62 116.17 23.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.842 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.75 -25.33 32.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 65.519999999999996 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -60.28 -38.03 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 110.921 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -102.92 -38.16 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.4 44.75 2.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.756 . . . . 64.409999999999997 112.482 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -147.68 169.14 20.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 61.140000000000001 110.909 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -177.05 -175.94 44.76 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 74.439999999999998 112.544 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -138.5 144.87 40.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.0 mt -121.17 141.43 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 111.134 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -109.01 121.84 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -105.17 -172.0 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 110.853 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -22.29 61.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 43.149999999999999 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -54.61 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 31.32 110.892 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.24 -67.94 0.16 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 43.020000000000003 112.517 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.3 35.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.628 2.218 . . . . 53.340000000000003 112.354 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -82.29 -173.71 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 64.209999999999994 110.833 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.726 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -139.8 151.55 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 111.177 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.83 114.87 22.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.92 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.72 144.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.450000000000003 111.131 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -146.01 159.42 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.922 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.835 ' HA ' HD12 ' A' ' 33' ' ' ILE . 10.0 p90 -58.72 -20.36 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.887 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.6 t -87.62 7.7 28.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -133.98 5.82 3.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 63.32 111.086 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 30' ' ' PHE . 58.1 mt -90.84 123.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 55.299999999999997 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -108.76 91.63 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 74.540000000000006 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.53 -179.58 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 111.064 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -108.48 74.3 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 65.25 110.843 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 139.83 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 64.0 112.49 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -53.31 110.31 0.54 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.868 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -159.82 166.81 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 110.825 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.3 p -115.79 -173.88 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 111.147 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.75 165.6 11.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.966 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -124.32 127.33 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.869 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HA ' HG13 ' A' ' 6' ' ' VAL . 57.5 tt0 -51.6 124.97 13.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.89 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.26 -15.01 47.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 44.409999999999997 112.464 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.86 158.32 19.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 75.510000000000005 110.861 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -92.78 139.74 30.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.844 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -155.12 143.26 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 73.230000000000004 111.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 65' ' ' VAL . 32.5 tt0 -87.88 162.12 17.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.009999999999998 110.899 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CD2' HG11 ' A' ' 26' ' ' VAL . 50.6 p90 -163.18 130.94 3.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.83 100.74 12.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 63.539999999999999 110.862 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.7 m -63.45 123.87 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.136 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -114.3 160.69 31.78 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 110.908 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -91.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.725 2.283 . . . . 71.030000000000001 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.2 63.22 4.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.772 -0.728 . . . . 54.210000000000001 112.492 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -133.97 -41.17 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.352 . . . . 74.430000000000007 110.87 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.74 144.62 16.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.734 -0.746 . . . . 44.399999999999999 112.483 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.36 -45.44 45.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 73.219999999999999 112.449 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -12.37 58.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.357 . . . . 54.420000000000002 110.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.26 -85.06 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 73.140000000000001 112.48 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 113.28 3.32 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 72.450000000000003 112.328 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 tt0 -113.33 164.77 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 110.96 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.82 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.08 56.15 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.43 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.17 -49.28 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 64.420000000000002 110.921 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -123.06 98.95 6.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.85 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.82 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.45 143.67 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 63.350000000000001 111.113 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -132.39 153.75 50.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -91.66 132.41 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.905 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 111.108 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.848 0.356 . . . . 64.430000000000007 110.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -122.88 152.54 40.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 110.897 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 1.8 mttm -115.02 140.82 48.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.65 167.59 40.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 61.119999999999997 112.443 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 p -79.83 157.62 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 63.329999999999998 111.16 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.8 p -98.03 134.33 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.438 . . . . 64.420000000000002 111.135 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.63 -35.66 22.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.911 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -170.1 142.62 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 110.908 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 33' ' ' ILE . 59.1 t80 -136.79 102.98 5.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 110.933 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -81.03 104.39 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 53.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.81 -21.63 57.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 54.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.78 -35.72 82.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -104.07 -38.91 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.925 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.28 45.01 1.77 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 72.340000000000003 112.48 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -145.62 168.77 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.94 0.4 . . . . 75.310000000000002 110.925 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.6 174.22 46.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.762 . . . . 65.5 112.492 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.63 135.28 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 73.340000000000003 110.894 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 26' ' ' VAL . 29.8 mt -117.11 148.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.106 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.643 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -119.81 125.3 48.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.37 -169.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.916 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -84.04 -20.59 32.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.439999999999998 110.859 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -132.65 77.39 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.871 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.72 74.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 53.5 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 19' ' ' GLN . 53.8 Cg_endo -69.8 164.41 34.7 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 74.209999999999994 112.346 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.3 91.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.849 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.691 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -116.05 147.29 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 111.152 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -73.11 114.4 11.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.876 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.39 145.02 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 111.158 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -145.13 161.57 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.878 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.807 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.9 p90 -60.38 -18.03 47.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.81 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -88.35 3.09 51.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 111.107 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.84 -0.05 6.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 61.340000000000003 111.118 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.807 HD12 ' HA ' ' A' ' 30' ' ' PHE . 55.1 mt -87.36 128.99 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.349999999999994 111.11 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.83 86.23 2.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.12 174.88 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 53.310000000000002 111.129 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.76 76.66 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.879 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.87 -117.93 3.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 72.25 112.503 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -67.92 110.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 75.400000000000006 110.907 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -85.82 89.83 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.010000000000005 110.883 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.9 m -158.07 145.88 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 52.43 111.122 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.0 mp -114.72 166.19 12.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 62.530000000000001 110.875 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -128.36 127.42 42.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.7 tt0 -52.13 127.25 21.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.129999999999995 110.843 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.33 -10.05 59.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.682 -0.77 . . . . 42.149999999999999 112.452 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.1 160.28 16.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.897 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -95.68 138.9 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -155.49 142.67 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.439999999999998 111.144 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 65' ' ' VAL . 36.4 tt0 -87.27 159.26 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.886 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.4 p90 -159.24 132.94 7.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 51.32 110.928 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -98.25 99.72 10.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.898 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.2 m -63.34 125.62 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 54.549999999999997 111.111 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.97 159.19 45.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.656 0.741 . . . . 75.329999999999998 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.736 2.29 . . . . 72.129999999999995 112.341 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.85 60.66 4.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 55.210000000000001 112.466 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -131.13 -39.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 62.130000000000003 110.848 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.407 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -109.01 149.05 17.01 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.73 . . . . 43.32 112.443 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.14 -57.34 9.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 73.150000000000006 112.473 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -10.68 59.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.099999999999994 110.887 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.34 -79.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 112.85 3.17 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.263 . . . . 63.0 112.382 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.94 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -117.02 165.55 13.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.905 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.815 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -89.54 57.99 4.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.082 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -40.51 -46.99 2.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.889 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.7 tppt? -125.36 101.47 6.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 110.86 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.815 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.64 144.09 16.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 62.329999999999998 111.128 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 1.5 mmm180 -133.7 152.46 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.881 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.536 ' O ' HD13 ' A' ' 68' ' ' ILE . 28.0 ttp85 -87.25 134.18 33.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 64.420000000000002 110.873 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 67' ' ' ARG . 6.8 mm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 62.539999999999999 111.163 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.815 0.34 . . . . 72.25 110.903 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -118.16 152.93 34.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 60.520000000000003 110.914 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 23.3 mtmt -116.45 136.79 52.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.887 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.24 162.99 36.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.756 -0.735 . . . . 22.219999999999999 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -75.87 156.32 34.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 74.049999999999997 111.097 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.7 p -99.09 135.05 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 111.104 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -88.06 -33.01 18.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 110.909 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -171.21 138.86 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.957 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.669 ' CE2' HD23 ' A' ' 41' ' ' LEU . 55.9 t80 -133.86 99.11 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 74.420000000000002 110.885 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.81 91.38 2.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 71.299999999999997 110.867 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.49 74.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.08 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -60.12 -41.07 91.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.85 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 -36.45 18.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 55.43 110.914 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.99 24.15 10.04 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.200000000000003 112.493 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -133.58 175.65 9.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.943 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.51 171.53 44.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.724 -0.751 . . . . 72.239999999999995 112.469 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -131.57 135.1 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.329999999999998 110.862 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' HB ' HG12 ' A' ' 26' ' ' VAL . 27.0 mt -116.26 151.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 53.399999999999999 111.12 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -120.36 120.98 37.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 65.129999999999995 110.91 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -115.2 -168.16 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 110.867 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.62 -23.17 29.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 64.549999999999997 110.869 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -138.66 79.29 1.72 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 62.140000000000001 110.837 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.41 68.29 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 52.350000000000001 112.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 175.39 8.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 50.219999999999999 112.354 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 41.16 73.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 61.140000000000001 110.87 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.639 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -98.44 146.99 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 75.349999999999994 111.1 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.34 113.96 12.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.925 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.85 140.02 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 41.100000000000001 111.121 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -129.23 157.83 40.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.88 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 33' ' ' ILE . 8.5 p90 -66.14 -14.18 61.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 110.841 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -91.8 -7.3 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 111.165 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -107.92 -14.0 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.131 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 30' ' ' PHE . 3.9 mt -67.51 126.79 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 60.119999999999997 111.13 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -112.04 94.14 4.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 70.099999999999994 110.897 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.07 179.28 6.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 44.539999999999999 111.073 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -99.68 74.22 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 65.439999999999998 110.884 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.68 127.97 3.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 61.32 112.489 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -52.6 111.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 110.917 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.61 -169.45 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.927 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -128.26 179.04 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 111.111 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.669 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.1 mm? -108.69 163.76 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.949 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.0 127.09 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 72.230000000000004 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.613 ' HA ' HG13 ' A' ' 6' ' ' VAL . 74.4 tt0 -52.89 126.2 19.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.88 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.61 -11.58 56.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.746 -0.74 . . . . 52.210000000000001 112.518 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -87.49 159.63 18.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.391 . . . . 73.400000000000006 110.853 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -94.85 139.25 31.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 72.409999999999997 110.84 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG11 HD12 ' A' ' 41' ' ' LEU . 33.3 m -155.06 142.77 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.183 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.662 ' O ' HG22 ' A' ' 65' ' ' VAL . 31.1 tt0 -86.65 160.61 18.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HG11 ' A' ' 26' ' ' VAL . 46.9 p90 -162.16 130.33 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 62.520000000000003 110.84 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -95.5 100.57 12.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.019999999999996 110.89 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.942 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.9 m -61.61 122.86 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.089 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' H ' ' H ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -109.47 158.71 33.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.636 0.732 . . . . 73.25 110.877 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.26 . . . . 65.430000000000007 112.384 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.49 61.86 4.7 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 51.310000000000002 112.504 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -132.22 -39.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.349 . . . . 72.109999999999999 110.897 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -102.42 146.38 16.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.792 -0.718 . . . . 43.549999999999997 112.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -53.22 18.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.795 -0.717 . . . . 50.009999999999998 112.496 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.46 -10.69 59.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 61.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.7 -78.29 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 43.310000000000002 112.513 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 113.32 3.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 112.328 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.942 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -114.19 163.32 15.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.891 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.75 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -90.04 58.33 4.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.103 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -43.0 -51.58 5.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 53.210000000000001 110.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -120.43 101.2 7.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 63.299999999999997 110.89 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.75 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -103.96 144.57 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.099999999999994 111.107 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.6 mtt180 -132.55 154.22 50.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 63.43 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -91.44 132.26 36.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 70.239999999999995 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.138 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.834 0.349 . . . . 62.32 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -108.63 172.15 7.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.881 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 10.7 mttm -139.41 128.51 23.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.846 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.49 172.85 40.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.691 -0.766 . . . . 63.219999999999999 112.441 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.1 p -78.74 158.6 28.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 111.107 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.1 p -99.69 134.43 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 111.111 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.5 OUTLIER -80.55 -36.26 33.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.530000000000001 110.904 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -176.73 145.48 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.885 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 43.8 t80 -135.13 100.3 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 65.450000000000003 110.816 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -78.06 107.04 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 72.519999999999996 110.9 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.72 -22.27 54.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 65.420000000000002 111.126 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -65.68 -29.86 70.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.200000000000003 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -109.08 -39.77 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.938 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.93 41.81 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 72.0 112.483 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -140.35 173.42 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.932 0.396 . . . . 74.209999999999994 110.919 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -176.02 170.4 43.29 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.709 -0.758 . . . . 35.009999999999998 112.468 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -130.88 134.06 46.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 55.200000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.502 ' HB ' HG12 ' A' ' 26' ' ' VAL . 34.0 mt -116.48 149.25 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 74.510000000000005 111.122 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.634 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.77 128.81 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.906 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.57 173.99 10.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.915 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -70.37 -16.11 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 74.219999999999999 110.935 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -137.6 76.79 1.6 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 71.340000000000003 110.896 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.66 72.21 0.51 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.762 . . . . 24.32 112.503 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 166.22 28.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.248 . . . . 74.109999999999999 112.36 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.35 81.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 54.329999999999998 110.879 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 51' ' ' VAL . 1.4 p -102.06 151.15 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 64.420000000000002 111.149 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.64 115.05 17.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.209999999999994 110.851 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.92 143.66 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 111.156 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -144.98 161.15 40.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.841 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.868 ' HA ' HD12 ' A' ' 33' ' ' ILE . 19.1 p90 -59.86 -18.74 46.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 61.329999999999998 110.861 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.76 2.82 40.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 62.119999999999997 111.161 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.19 -33.0 3.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 30' ' ' PHE . 14.0 mt -52.34 128.33 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.148 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -99.95 87.86 3.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 53.310000000000002 110.891 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.37 166.38 23.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 64.219999999999999 111.102 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.65 74.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.439999999999998 110.888 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.78 -159.34 17.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 61.399999999999999 112.514 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -96.67 111.06 23.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 73.140000000000001 110.85 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.45 110.36 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 110.85 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.2 p -79.73 -175.7 5.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 64.140000000000001 111.16 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 9' ' ' PHE . 3.0 mm? -110.0 169.3 8.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.859 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -125.42 129.03 49.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.615 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.7 tt0 -52.73 131.67 35.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 61.210000000000001 110.882 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.27 -12.57 65.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 71.439999999999998 112.423 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.41 160.33 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 71.540000000000006 110.905 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.81 140.53 29.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.84 141.36 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.127 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.597 ' O ' HG22 ' A' ' 65' ' ' VAL . 3.1 tt0 -86.42 156.04 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 64.400000000000006 110.867 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD2' HG11 ' A' ' 26' ' ' VAL . 39.8 p90 -156.9 132.89 9.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.853 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -100.2 99.57 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 110.866 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.909 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 23.8 m -60.96 126.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 111.095 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.6 mt-10 -118.67 158.49 47.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 61.240000000000002 110.866 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 -90.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.369 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 62.3 4.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 63.409999999999997 112.494 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -40.22 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.828 0.347 . . . . 72.230000000000004 110.866 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -107.81 148.2 16.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 41.399999999999999 112.46 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -55.25 13.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 71.140000000000001 112.481 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -71.52 -12.38 61.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 71.510000000000005 110.901 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.57 -79.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.485 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 112.32 3.05 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.363 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.909 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -115.18 165.35 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.909 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.842 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.56 56.97 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 54.329999999999998 111.075 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.15 -47.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 64.099999999999994 110.89 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -126.95 100.37 6.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.909 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.842 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.45 143.67 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 111.097 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -133.36 156.26 47.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.414 ' C ' HG12 ' A' ' 68' ' ' ILE . 47.5 mtm180 -92.09 134.41 34.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 110.838 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG12 ' C ' ' A' ' 67' ' ' ARG . 2.3 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.788 0.328 . . . . 65.209999999999994 110.886 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -101.47 170.96 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 64.340000000000003 110.874 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 11.2 mtpt -142.93 132.83 24.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.864 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.16 171.83 44.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 71.030000000000001 112.45 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -72.32 156.75 38.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.847 0.356 . . . . 71.010000000000005 111.129 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 43' ' ' GLU . 13.2 p -98.47 131.65 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 61.329999999999998 111.142 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -76.42 -36.03 58.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.907 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -176.79 145.12 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.954 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 41' ' ' LEU . 21.8 t80 -125.68 99.65 6.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 73.120000000000005 110.885 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 104.03 9.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.857 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.579 ' HB2' HG21 ' A' ' 40' ' ' THR . . . -82.91 -27.66 30.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 55.149999999999999 111.099 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.17 -23.27 62.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.429 . . . . 52.539999999999999 110.884 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -110.31 -40.11 4.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.109999999999999 110.86 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.27 37.56 3.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.727 . . . . 61.310000000000002 112.483 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.87 172.41 13.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 74.109999999999999 110.9 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -171.41 167.78 40.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 31.399999999999999 112.482 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -135.86 130.89 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.919 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 49' ' ' PHE . 17.9 mt -119.53 148.74 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 111.135 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.624 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -125.24 131.16 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.885 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.62 -175.61 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.944 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.49 -21.35 62.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 62.299999999999997 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -52.74 -72.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 70.109999999999999 110.889 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.23 -68.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.742 . . . . 71.420000000000002 112.515 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 168.78 20.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 65.109999999999999 112.397 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -89.2 177.43 6.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.219999999999999 110.862 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -127.89 151.53 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 44.119999999999997 111.115 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.868 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -123.04 142.3 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.136 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -130.12 159.14 37.69 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 75.329999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HA ' HD12 ' A' ' 33' ' ' ILE . 13.0 p90 -59.74 -19.2 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.88 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -89.99 -0.44 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.141 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -116.9 -23.51 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.079 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.737 HD12 ' HA ' ' A' ' 30' ' ' PHE . 6.4 mt -65.94 126.27 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 75.120000000000005 111.13 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -112.1 86.56 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.72 -179.94 3.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 61.130000000000003 111.061 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.2 74.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 73.519999999999996 110.828 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.69 139.38 5.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 72.349999999999994 112.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -52.57 110.09 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.859 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -169.88 165.83 9.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 70.239999999999995 110.866 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.579 HG21 ' HB2' ' A' ' 11' ' ' ALA . 47.5 p -115.85 -175.28 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 44.43 111.191 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 9' ' ' PHE . 4.4 mm? -108.95 179.25 4.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.428 . . . . 62.149999999999999 110.936 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -130.79 128.39 40.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 70.409999999999997 110.906 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.8 tt0 -52.7 120.4 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.918 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.46 -15.61 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 74.530000000000001 112.475 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -84.25 159.55 20.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 63.25 110.872 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.6 m-70 -90.74 140.43 29.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.857 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -153.39 140.99 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.131 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 65' ' ' VAL . 6.4 mt-10 -85.17 157.39 20.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.9 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 18' ' ' ILE . 51.1 p90 -159.98 132.05 6.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.917 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -97.81 99.76 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.919 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.3 m -62.29 124.24 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.319999999999993 111.146 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -111.56 156.29 41.62 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.726 . . . . 44.149999999999999 110.859 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.2 Cg_endo -69.8 -91.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.619 2.213 . . . . 55.530000000000001 112.36 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.08 4.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 41.25 112.479 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 2.1 tpm_? -132.36 -38.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 74.239999999999995 110.905 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.44 147.72 17.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 64.049999999999997 112.485 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.44 -57.74 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.666 -0.778 . . . . 62.439999999999998 112.506 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -74.04 -7.09 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 71.329999999999998 110.86 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.76 -80.65 0.34 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.759 . . . . 61.450000000000003 112.514 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 110.75 2.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.343 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.5 tt0 -114.54 162.21 17.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.540000000000006 110.917 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.767 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.76 57.5 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 62.119999999999997 111.122 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -40.03 -48.24 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.439999999999998 110.926 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.5 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -125.07 98.31 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.918 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.767 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -101.64 141.34 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 61.310000000000002 111.131 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -134.06 161.04 35.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.862 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -93.14 134.88 34.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.877 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.154 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' H1 ' ' HB2' ' A' ' 50' ' ' GLU . 1.6 tpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 62.329999999999998 110.881 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.1 145.97 48.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.878 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 61.8 mttt -114.39 133.93 55.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 74.120000000000005 110.916 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.83 42.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 72.349999999999994 112.492 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.43 140.16 38.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 63.43 111.154 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -78.21 130.72 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.138 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -74.99 -42.49 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.540000000000006 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 8' ' ' TRP . 2.4 p90 -172.63 148.11 1.9 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.893 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.68 ' CD1' HD23 ' A' ' 41' ' ' LEU . 34.6 t80 -137.32 104.82 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 110.878 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.71 96.14 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.904 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.47 -23.89 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 50.119999999999997 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -61.16 -35.89 78.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 110.83 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -101.28 -37.46 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.906 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.26 31.96 5.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.774 -0.727 . . . . 74.310000000000002 112.5 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -141.39 175.26 9.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.972 0.415 . . . . 62.119999999999997 110.919 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . 179.36 -178.6 48.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 71.329999999999998 112.516 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.09 144.24 45.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.838 0.351 . . . . 53.210000000000001 110.85 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 17.1 mt -117.62 147.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 45.100000000000001 111.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -111.55 112.51 24.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 72.109999999999999 110.939 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 3.1 pt20 -105.42 -168.69 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.89 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.51 -26.97 62.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 110.874 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 4.4 mm-40 -48.55 -74.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 63.100000000000001 110.943 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.81 -65.68 0.28 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 52.109999999999999 112.447 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.691 2.261 . . . . 70.430000000000007 112.37 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 169.66 17.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 110.876 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -128.19 151.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 111.123 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.45 116.35 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.899 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -125.59 142.6 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 63.43 111.135 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.417 ' HB3' HG22 ' A' ' 31' ' ' THR . 3.3 m-70 -142.8 158.47 43.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.88 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.872 ' HA ' HD12 ' A' ' 33' ' ' ILE . 23.2 p90 -59.69 -20.54 56.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 110.889 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 29' ' ' HIS . 8.8 t -85.0 0.38 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 53.130000000000003 111.149 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.56 -20.79 8.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 52.119999999999997 111.095 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.872 HD12 ' HA ' ' A' ' 30' ' ' PHE . 15.6 mt -64.8 127.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 111.128 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.23 86.78 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 73.200000000000003 110.858 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.91 163.79 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 111.088 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.08 74.37 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.450000000000003 110.835 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.86 -162.35 15.65 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.801 -0.714 . . . . 74.340000000000003 112.489 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -96.53 130.58 43.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 74.299999999999997 110.847 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.95 -178.78 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.878 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.5 p -139.37 -174.61 3.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 111.117 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.68 HD23 ' CD1' ' A' ' 9' ' ' PHE . 2.8 mm? -109.18 164.88 12.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.952 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -121.36 127.28 51.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.878 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.3 tt0 -53.92 121.65 8.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 62.5 110.879 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.98 -6.6 43.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 35.329999999999998 112.475 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -92.96 159.19 15.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -91.68 137.78 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.841 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 41' ' ' LEU . 33.8 m -156.38 142.16 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 111.13 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 65' ' ' VAL . 67.6 tt0 -90.23 159.95 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 53.25 110.885 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 26' ' ' VAL . 40.8 p90 -161.02 130.55 4.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 1.5 tt0 -97.25 101.9 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 70.439999999999998 110.841 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.922 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.2 m -64.15 123.86 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.147 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.13 158.52 36.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.647 0.737 . . . . 71.5 110.896 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -89.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.715 2.277 . . . . 65.209999999999994 112.397 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.61 61.22 4.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 44.299999999999997 112.466 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.37 -41.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 53.399999999999999 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.22 149.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.468 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.24 -57.9 8.55 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 72.230000000000004 112.459 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -9.89 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 73.010000000000005 110.876 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.46 -80.53 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.482 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 113.55 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 64.140000000000001 112.341 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.922 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -117.76 164.55 14.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 53.039999999999999 110.902 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.23 58.3 4.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 64.140000000000001 111.079 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -43.49 5.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -127.61 98.41 5.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.908 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.833 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -105.39 142.6 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 75.099999999999994 111.126 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.19 153.67 51.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 110.895 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' C ' HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -91.18 134.25 34.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.866 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.5 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 111.124 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.803 0.335 . . . . 63.420000000000002 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -108.79 163.4 13.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.856 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.1 mtmt -136.68 133.16 35.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.896 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.69 171.79 42.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.756 -0.735 . . . . 74.120000000000005 112.477 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -75.58 156.84 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 75.019999999999996 111.151 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.652 HG13 ' HA ' ' A' ' 43' ' ' GLU . 11.2 p -97.73 132.61 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 111.103 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' N ' HE22 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.01 -35.48 42.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.872 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -176.2 145.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.927 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CE1' HD23 ' A' ' 41' ' ' LEU . 50.2 t80 -136.9 115.23 11.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.885 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -99.0 117.43 33.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.907 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.3 -22.45 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 62.039999999999999 111.129 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.06 -25.76 67.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 -40.28 3.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.85 50.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.719 -0.753 . . . . 64.540000000000006 112.469 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 27.2 p90 -146.45 167.18 24.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.957 0.408 . . . . 54.539999999999999 110.866 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.56 172.47 44.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.030000000000001 112.451 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.62 134.06 38.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 74.040000000000006 110.854 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.5 mt -119.38 146.85 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 111.066 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.627 ' N ' HE21 ' A' ' 19' ' ' GLN . 0.0 OUTLIER -120.72 124.86 46.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.010000000000005 110.911 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -101.25 -174.47 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 61.530000000000001 110.959 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.65 -23.44 66.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 74.219999999999999 110.851 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.91 -69.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.874 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.7 -68.1 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 61.340000000000003 112.493 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.42 21.61 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.652 2.235 . . . . 72.150000000000006 112.324 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -88.27 -176.48 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.902 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -133.63 151.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 111.107 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -88.37 115.51 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 70.049999999999997 110.865 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.49 145.16 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 111.096 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.6 m-70 -146.92 163.35 36.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.853 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.864 ' HA ' HD12 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -58.91 -19.53 43.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.049999999999997 110.866 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.9 p -85.14 4.88 32.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.200000000000003 111.141 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.37 -33.85 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.092 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 30' ' ' PHE . 25.3 mt -50.74 130.35 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 111.15 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -103.14 89.23 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 54.409999999999997 110.876 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.2 174.52 10.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 55.229999999999997 111.08 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.29 76.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 110.848 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.02 -154.69 16.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 64.409999999999997 112.5 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -93.62 116.03 28.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 74.049999999999997 110.91 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -154.8 169.21 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.881 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.4 p -149.39 175.22 11.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.144 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CE1' ' A' ' 9' ' ' PHE . 2.6 mm? -109.05 169.05 8.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 74.019999999999996 110.938 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 42.240000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.1 tt0 -51.47 130.65 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.912 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.97 -15.92 58.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 60.409999999999997 112.477 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.51 159.29 18.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 71.340000000000003 110.886 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 68' ' ' ILE . 2.0 m-70 -92.87 141.09 28.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.863 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.7 m -153.14 141.16 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.148 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.2 mt-10 -82.81 162.47 21.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 63.329999999999998 110.905 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 51.3 p90 -166.93 130.88 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.904 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -98.07 100.91 12.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.875 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.91 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.0 m -63.58 122.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.1 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -118.09 161.27 35.55 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.641 0.734 . . . . 72.319999999999993 110.91 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.8 Cg_endo -69.74 -89.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 63.149999999999999 112.322 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.92 61.16 3.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 74.299999999999997 112.483 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -131.1 -41.34 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.876 0.37 . . . . 74.349999999999994 110.928 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' N ' ' HB2' ' A' ' 61' ' ' GLN . . . -113.21 148.67 18.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 53.149999999999999 112.494 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.84 -55.4 14.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.74 . . . . 51.030000000000001 112.474 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -12.93 61.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 74.530000000000001 110.934 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.16 -79.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 74.349999999999994 112.479 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.09 3.59 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.729 2.286 . . . . 71.409999999999997 112.37 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.91 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 5.1 tm0? -117.43 164.38 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.886 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.782 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -87.56 55.72 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.539999999999999 111.075 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.63 -39.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.200000000000003 110.894 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.35 92.77 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.120000000000005 110.877 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -99.34 139.23 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -133.91 161.8 33.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.933 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -92.23 134.84 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.117 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' H1 ' ' HA ' ' A' ' 50' ' ' GLU . 3.1 ttt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 74.239999999999995 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -114.96 141.55 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 74.420000000000002 110.866 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 22.2 mtmt -114.62 134.34 55.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 171.47 41.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 73.120000000000005 112.477 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 p -79.61 158.1 27.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.818 0.342 . . . . 73.329999999999998 111.155 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 43' ' ' GLU . 7.3 p -101.2 135.2 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 111.143 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -35.4 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 44.539999999999999 110.901 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.6 p90 -169.21 141.7 2.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 74.430000000000007 110.909 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 33' ' ' ILE . 45.6 t80 -142.92 101.18 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.922 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -84.61 120.68 26.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 70.219999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.49 -20.49 29.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 51.130000000000003 111.126 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -62.98 -36.92 85.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 110.912 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -39.4 7.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 110.903 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.0 40.29 2.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 75.209999999999994 112.501 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 1.3 p90 -142.05 170.5 15.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 75.340000000000003 110.945 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.41 173.21 45.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 73.219999999999999 112.502 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -132.18 135.48 46.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.373 . . . . 74.420000000000002 110.831 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 ' HB ' HG12 ' A' ' 26' ' ' VAL . 28.8 mt -116.2 147.86 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.127 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 24.3 mp0 -116.83 121.78 42.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 61.119999999999997 110.934 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -112.66 -171.39 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 110.878 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -84.23 -18.68 35.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 61.119999999999997 110.899 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.36 78.28 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 61.140000000000001 110.871 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 73.69 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 74.450000000000003 112.457 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 19' ' ' GLN . 53.8 Cg_endo -69.78 163.2 39.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 72.319999999999993 112.371 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.24 88.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 65.409999999999997 110.891 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.787 HG21 HG12 ' A' ' 51' ' ' VAL . 2.3 p -114.29 149.46 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 53.509999999999998 111.118 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.19 113.75 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -128.62 143.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 64.299999999999997 111.14 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 22.1 m-70 -145.48 161.01 40.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.867 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 33' ' ' ILE . 27.8 p90 -60.27 -18.06 46.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.866 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -85.54 3.51 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.98 -32.17 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 73.030000000000001 111.099 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 30' ' ' PHE . 12.3 mt -51.39 128.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.128 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.37 86.78 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.884 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.85 169.3 16.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 53.009999999999998 111.097 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.43 74.48 3.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 65.230000000000004 110.852 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.6 139.42 5.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 60.439999999999998 112.49 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -52.59 110.32 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 61.549999999999997 110.89 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -138.29 -170.14 2.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 75.530000000000001 110.838 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -143.26 174.47 10.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 111.166 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.01 163.4 13.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 110.924 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -124.37 128.61 49.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 45.140000000000001 110.854 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.635 ' HA ' HG13 ' A' ' 6' ' ' VAL . 86.2 tt0 -52.74 129.27 29.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 64.540000000000006 110.879 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.48 -13.25 61.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 44.210000000000001 112.473 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.71 160.09 18.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 73.439999999999998 110.895 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 68' ' ' ILE . 5.1 m-70 -95.02 139.0 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.889 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HG13 ' A' ' 68' ' ' ILE . 32.8 m -154.57 142.96 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 111.133 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' O ' HG22 ' A' ' 65' ' ' VAL . 44.4 tt0 -86.93 163.54 17.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 26' ' ' VAL . 45.0 p90 -166.42 131.68 2.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 70.430000000000007 110.858 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 1.6 mm-40 -97.41 100.89 12.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.496 . . . . 72.129999999999995 110.861 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.926 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.1 m -65.28 122.4 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 111.15 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -116.82 159.37 40.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.635 0.731 . . . . 73.349999999999994 110.894 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.74 -89.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.74 2.294 . . . . 73.420000000000002 112.349 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.03 60.01 3.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.741 . . . . 71.299999999999997 112.465 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 -41.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 70.129999999999995 110.891 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.79 149.07 17.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 64.329999999999998 112.504 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.04 8.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.531 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -68.21 -12.22 60.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 74.430000000000007 110.882 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.09 -80.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 71.299999999999997 112.481 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 113.97 3.54 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.343 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.926 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -118.22 165.56 13.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 110.91 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.817 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -88.03 57.0 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.99 -42.36 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 110.907 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -131.84 98.68 4.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.89 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.817 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.54 143.62 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 111.085 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -132.92 151.13 52.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 75.030000000000001 110.862 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.81 133.93 34.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.909 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 47' ' ' VAL . 1.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.1 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.852 0.358 . . . . 70.450000000000003 110.901 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -146.83 159.34 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.896 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.6 mtmt -113.03 134.36 54.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 110.893 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.0 172.1 38.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 52.100000000000001 112.485 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 p -76.46 152.25 36.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 72.209999999999994 111.126 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.4 p -95.04 128.03 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.430000000000007 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -71.81 -38.5 70.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.209999999999994 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -175.75 150.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.902 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.9 t80 -141.93 99.64 3.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 64.340000000000003 110.844 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.59 119.1 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 73.310000000000002 110.91 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.49 -21.75 35.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -62.45 -33.48 74.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 71.209999999999994 110.878 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -106.81 -39.13 5.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.845 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.6 44.34 2.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 72.409999999999997 112.487 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -143.39 166.64 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 110.924 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -163.6 177.4 39.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 74.140000000000001 112.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -140.99 124.61 16.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.8 0.333 . . . . 71.150000000000006 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.905 HD12 HG11 ' A' ' 28' ' ' VAL . 6.0 mt -118.36 150.91 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.450000000000003 111.162 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.33 127.52 35.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.895 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -95.05 -169.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.92 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.01 -18.56 47.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 64.329999999999998 110.932 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -55.73 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.885 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.44 -65.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 62.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 166.39 27.8 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.644 2.23 . . . . 73.140000000000001 112.357 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 -173.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 45.310000000000002 110.842 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.933 HG21 HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -139.9 152.26 22.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.17 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -85.97 114.84 23.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.916 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.905 HG11 HD12 ' A' ' 18' ' ' ILE . 1.9 m -123.73 153.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.126 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -149.27 160.33 43.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.851 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.9 p90 -58.84 -19.58 42.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.48 4.72 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.111 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.03 -32.97 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 111.146 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.2 mt -51.38 132.67 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 70.420000000000002 111.132 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -112.02 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.882 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.26 13.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 111.072 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.66 76.02 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.457 . . . . 64.140000000000001 110.834 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.67 -121.1 4.24 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.756 -0.735 . . . . 74.549999999999997 112.498 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -55.14 110.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 62.32 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.75 45.72 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 65.230000000000004 110.869 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -121.21 142.56 49.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 111.123 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.0 mm? -111.96 175.88 5.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.943 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -129.89 128.43 42.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 74.209999999999994 110.885 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 56.1 tt0 -52.14 133.28 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.863 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.18 -12.95 68.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 70.450000000000003 112.497 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -86.61 159.64 19.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.903 0.382 . . . . 55.530000000000001 110.892 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -92.65 139.6 30.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.886 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -155.99 141.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 75.530000000000001 111.114 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 65' ' ' VAL . 30.8 tt0 -86.13 161.11 19.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 62.149999999999999 110.893 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.7 p90 -162.41 132.19 4.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 63.149999999999999 110.885 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 7.7 mt-10 -98.62 99.71 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 75.450000000000003 110.945 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 HG21 ' A' ' 26' ' ' VAL . 18.9 m -63.0 126.75 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.12 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.2 mm-40 -115.23 161.61 28.76 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.729 . . . . 74.349999999999994 110.908 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -90.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.715 2.277 . . . . 43.329999999999998 112.345 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.09 63.02 4.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 54.119999999999997 112.482 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -130.7 -41.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 64.319999999999993 110.918 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -105.94 147.76 16.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 54.530000000000001 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.15 -51.8 24.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 74.230000000000004 112.469 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -14.79 60.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.916 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.44 -77.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 65.349999999999994 112.531 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 113.06 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.340000000000003 112.337 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.88 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 25.5 tt0 -117.43 154.68 30.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 53.130000000000003 110.954 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.823 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -83.72 60.96 6.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 111.095 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -45.19 -43.43 10.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.150000000000006 110.926 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -125.28 99.61 6.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 75.329999999999998 110.88 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.774 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -103.68 143.7 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 65.140000000000001 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -132.43 153.98 50.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.848 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' C ' HG12 ' A' ' 68' ' ' ILE . 56.0 mtp180 -91.41 133.31 35.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 64.510000000000005 110.811 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.405 HG12 ' C ' ' A' ' 67' ' ' ARG . 1.7 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.869 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.9 150.34 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.450000000000003 110.866 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -123.21 134.19 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.875 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.61 44.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.733 . . . . 52.210000000000001 112.512 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 p -73.75 157.73 35.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 111.091 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -96.21 127.99 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 111.107 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -72.04 -42.02 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.87 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -172.15 148.01 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 65.329999999999998 110.903 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' HD11 ' A' ' 33' ' ' ILE . 42.7 t80 -137.51 105.89 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 70.019999999999996 110.854 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -90.51 100.67 13.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 72.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.58 64.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 63.5 111.098 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.25 -37.37 82.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.888 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -99.9 -38.91 8.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.904 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.35 37.92 3.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.718 -0.753 . . . . 72.239999999999995 112.472 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.71 169.53 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.120000000000005 110.922 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -173.44 179.71 44.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.409999999999997 112.473 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -136.27 140.08 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 71.010000000000005 110.892 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 49' ' ' PHE . 19.8 mt -119.32 138.14 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.340000000000003 111.138 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -106.62 123.79 48.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.905 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -107.13 -171.81 1.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 110.899 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.45 -23.81 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.898 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -52.67 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.109999999999999 110.868 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.23 -66.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.458 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 164.71 33.46 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.696 2.264 . . . . 74.209999999999994 112.384 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.44 -174.09 4.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 110.874 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.731 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -139.83 151.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 111.14 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -87.88 114.84 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.92 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -122.92 145.89 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 111.133 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB3' HG22 ' A' ' 31' ' ' THR . 1.7 m-70 -145.21 160.04 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 63.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.844 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.8 p90 -61.48 -17.74 55.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 53.329999999999998 110.891 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 29' ' ' HIS . 9.4 t -85.78 6.07 29.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 64.519999999999996 111.158 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -127.04 -32.3 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 111.094 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 30' ' ' PHE . 24.9 mt -50.47 127.85 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.009999999999998 111.057 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -108.99 89.53 3.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 64.109999999999999 110.909 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.5 176.89 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 111.066 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.17 76.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 75.439999999999998 110.878 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.56 -137.2 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.340000000000003 112.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -71.98 110.11 6.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 72.400000000000006 110.88 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HB3' HG21 ' A' ' 33' ' ' ILE . 13.4 mtm-85 -75.27 127.03 32.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.912 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -166.46 131.19 2.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.141 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 mp -114.32 164.05 14.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 65.530000000000001 110.936 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -128.4 127.86 43.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 62.509999999999998 110.878 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HA ' HG13 ' A' ' 6' ' ' VAL . 49.5 tt0 -51.32 127.01 18.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.049999999999997 110.859 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.8 -15.85 56.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 35.219999999999999 112.49 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -85.89 157.4 20.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 51.409999999999997 110.862 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -90.33 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 72.219999999999999 110.836 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.0 m -155.21 142.5 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 111.147 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.586 ' O ' HG22 ' A' ' 65' ' ' VAL . 42.7 tt0 -87.17 162.7 17.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CD2' HG11 ' A' ' 26' ' ' VAL . 44.8 p90 -165.98 129.34 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.907 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 64' ' ' LYS . 3.6 tt0 -96.64 102.25 14.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.903 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.938 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -64.34 124.53 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 111.134 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -111.64 161.01 27.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.643 0.735 . . . . 75.349999999999994 110.865 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -91.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 72.329999999999998 112.331 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.07 63.22 4.44 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.773 -0.727 . . . . 24.129999999999999 112.473 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -41.47 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.879 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.72 150.32 16.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 73.25 112.493 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.13 -57.89 8.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 44.420000000000002 112.469 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.27 -11.11 60.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 110.91 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.55 -79.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.209999999999994 112.502 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 112.57 3.11 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.708 2.272 . . . . 61.140000000000001 112.332 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.938 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -114.74 162.49 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 63.340000000000003 110.909 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -85.84 57.53 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.129999999999995 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -44.22 -46.95 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.903 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -121.9 96.04 4.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.409999999999997 110.934 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -100.85 143.37 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 111.101 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -132.8 153.96 50.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 110.846 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -92.04 132.37 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 61.200000000000003 110.883 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 63.009999999999998 111.148 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 63.240000000000002 110.871 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -141.65 138.35 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 110.894 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.6 mptt -117.88 146.03 44.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 73.109999999999999 110.893 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.82 171.08 44.24 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.481 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -73.71 158.22 35.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 71.450000000000003 111.131 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.616 HG13 ' HA ' ' A' ' 43' ' ' GLU . 9.4 p -100.78 130.41 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.439999999999998 111.127 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -33.47 33.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 63.100000000000001 110.916 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -172.41 142.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 75.030000000000001 110.937 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HE2' HD11 ' A' ' 33' ' ' ILE . 45.3 t80 -140.86 99.32 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 51.119999999999997 110.881 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -79.16 86.71 4.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 110.917 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' OG1' ' A' ' 40' ' ' THR . . . -57.77 -25.08 60.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 50.520000000000003 111.13 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -67.8 -34.46 76.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.895 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -91.47 -37.42 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.25 110.909 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.25 8.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 70.25 112.471 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -135.38 171.99 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.933 0.396 . . . . 73.510000000000005 110.904 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.26 168.87 41.99 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 73.329999999999998 112.45 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -133.32 132.26 41.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 75.030000000000001 110.876 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -118.15 150.28 20.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 64.329999999999998 111.173 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -125.71 119.05 26.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.957 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -96.53 -169.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 110.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -66.56 -23.7 66.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.888 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.2 mm-40 -51.3 -70.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 72.209999999999994 110.887 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.55 -66.9 0.24 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 73.129999999999995 112.527 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 165.9 29.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.671 2.248 . . . . 72.450000000000003 112.325 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -82.66 -174.87 5.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 110.845 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -138.47 151.59 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 111.138 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.13 115.24 24.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.881 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -123.58 142.06 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 60.420000000000002 111.143 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -133.23 157.9 44.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 55.200000000000003 110.845 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.845 ' HA ' HD12 ' A' ' 33' ' ' ILE . 11.2 p90 -61.11 -18.29 57.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 70.439999999999998 110.865 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -89.51 0.31 56.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.230000000000004 111.117 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -117.04 -20.69 9.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 75.450000000000003 111.117 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 30' ' ' PHE . 16.9 mt -63.64 125.59 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.420000000000002 111.145 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.35 89.32 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 65.430000000000007 110.853 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.7 175.74 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 45.350000000000001 111.116 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -102.0 74.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.913 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.66 132.84 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 63.409999999999997 112.476 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -52.69 110.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 110.851 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -146.87 -169.7 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 74.329999999999998 110.891 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.651 ' OG1' ' HB2' ' A' ' 11' ' ' ALA . 13.4 t -134.71 177.02 8.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 111.126 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.3 mt -108.85 163.55 13.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -124.01 127.68 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 61.009999999999998 110.88 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.616 ' HA ' HG13 ' A' ' 6' ' ' VAL . 34.2 tt0 -51.67 128.75 24.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 110.884 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.75 -14.79 57.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 31.34 112.489 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -85.7 158.48 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.109999999999999 110.933 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 m-70 -95.07 139.99 30.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.859 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 m -153.05 140.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 111.123 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 65' ' ' VAL . 11.0 mt-10 -83.36 158.86 22.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.5 110.893 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 26' ' ' VAL . 48.2 p90 -162.83 130.93 3.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 72.319999999999993 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 100.45 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 72.010000000000005 110.894 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 20.2 m -64.83 126.28 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 111.092 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -113.93 160.8 30.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 73.099999999999994 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -90.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.706 2.271 . . . . 70.150000000000006 112.365 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.66 61.52 4.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 63.049999999999997 112.461 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 -40.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.9 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 148.48 16.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 71.540000000000006 112.47 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.31 -56.6 10.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.349999999999994 112.513 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -72.09 -8.78 56.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 74.319999999999993 110.913 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.87 -80.26 0.34 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.718 -0.753 . . . . 64.219999999999999 112.498 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 111.46 2.81 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 73.349999999999994 112.344 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.933 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.8 tt0 -115.71 159.19 21.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 72.230000000000004 110.908 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -83.66 58.78 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 51.509999999999998 111.11 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.48 -44.16 5.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.918 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -127.81 98.14 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 72.310000000000002 110.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.795 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -100.98 142.76 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 64.299999999999997 111.122 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -133.81 162.28 32.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.896 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -93.61 134.23 36.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.871 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 46' ' ' HIS . 1.3 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 111.14 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H3 ' ' HA ' ' A' ' 50' ' ' GLU . 5.8 ttm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 71.310000000000002 110.889 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -107.18 132.14 53.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 70.129999999999995 110.904 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 37.5 mtpt -109.65 133.28 53.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 63.509999999999998 110.883 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.55 171.9 42.27 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 74.230000000000004 112.507 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -78.15 157.9 29.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 74.129999999999995 111.099 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 43' ' ' GLU . 10.5 p -99.18 130.97 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 51.240000000000002 111.091 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -78.96 -35.22 43.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.907 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -174.44 144.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HE1' HD11 ' A' ' 33' ' ' ILE . 54.1 t80 -133.31 101.75 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.911 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -81.65 87.8 6.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 71.150000000000006 110.928 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' CB ' HG21 ' A' ' 40' ' ' THR . . . -63.81 -26.48 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.135 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.62 -28.03 69.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.896 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.84 -33.84 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.05 24.73 9.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.519 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -129.1 175.35 8.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 74.140000000000001 110.945 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' CA ' HG22 ' A' ' 28' ' ' VAL . . . -172.14 169.04 42.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 75.510000000000005 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' VAL . 27.2 m-85 -134.03 135.09 43.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 74.310000000000002 110.84 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.8 mt -121.36 142.93 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 55.450000000000003 111.105 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 7' ' ' LYS . 1.3 mm-40 -114.78 117.94 32.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.888 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 15.3 pt20 -100.45 -168.14 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.929 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.51 -23.93 61.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 110.863 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 20' ' ' GLN . 1.9 mm-40 -49.97 -73.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.897 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.98 -66.25 0.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 33.210000000000001 112.484 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 159.5 53.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 72.430000000000007 112.317 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.36 -177.47 3.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 70.219999999999999 110.841 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.704 HG21 HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -139.52 151.35 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 111.112 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.78 115.59 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 110.88 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 ' CA ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -122.87 142.19 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 61.149999999999999 111.157 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -130.39 157.59 42.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.858 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' HA ' HD12 ' A' ' 33' ' ' ILE . 9.5 p90 -62.39 -17.86 60.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -87.91 -1.41 57.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 75.140000000000001 111.183 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -114.22 -25.13 8.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 42.119999999999997 111.089 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 30' ' ' PHE . 7.1 mt -57.73 125.04 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 111.133 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -108.73 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.904 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.12 175.52 9.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.0 111.077 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.26 74.33 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 72.439999999999998 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.99 143.54 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 62.310000000000002 112.5 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -54.79 111.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.851 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -156.05 163.64 39.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 73.430000000000007 110.892 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.405 HG21 ' CB ' ' A' ' 11' ' ' ALA . 68.3 p -116.67 -174.76 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 111.18 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD22 HG11 ' A' ' 47' ' ' VAL . 38.2 mt -109.06 163.64 13.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 74.510000000000005 110.914 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -124.63 127.86 47.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 45.299999999999997 110.915 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 6' ' ' VAL . 26.8 tt0 -51.61 126.74 18.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 53.119999999999997 110.92 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.84 -12.45 56.27 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.724 -0.751 . . . . 54.100000000000001 112.483 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -88.56 159.75 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 72.239999999999995 110.887 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -95.16 139.88 30.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 110.837 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.619 HG11 HD22 ' A' ' 41' ' ' LEU . 33.8 m -154.93 142.65 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.099999999999994 111.149 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' O ' HG22 ' A' ' 65' ' ' VAL . 43.8 tt0 -88.48 160.05 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.913 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 26' ' ' VAL . 41.6 p90 -160.64 132.25 5.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 110.919 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.2 100.34 11.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.887 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.941 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.2 m -64.68 124.48 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 44.530000000000001 111.14 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.74 159.37 37.52 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.671 0.748 . . . . 64.430000000000007 110.896 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -90.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.654 2.236 . . . . 74.140000000000001 112.346 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.36 61.55 4.59 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.704 -0.76 . . . . 74.299999999999997 112.498 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -131.3 -40.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 71.530000000000001 110.862 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.43 150.3 16.8 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 54.340000000000003 112.473 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.92 -58.38 7.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 60.240000000000002 112.512 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.89 -10.09 57.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 73.040000000000006 110.886 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.23 -80.27 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 71.219999999999999 112.526 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 112.11 3.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.267 . . . . 63.210000000000001 112.327 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.941 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.1 tt0 -116.1 163.64 15.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -86.84 58.86 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.084 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -42.63 -49.07 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 73.299999999999997 110.881 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -123.13 99.41 6.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.420000000000002 110.938 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -101.8 145.03 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.16 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -132.5 155.63 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.875 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.4 132.37 37.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.857 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.530000000000001 111.13 179.97 . . . . . . . . 0 0 . 1 stop_ save_